Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neurooncol

Retrieve available abstracts of 430 articles:
HTML format



Single Articles


    October 2021
  1. SOHN B, An C, Kim D, Ahn SS, et al
    Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant.
    J Neurooncol. 2021 Oct 14. pii: 10.1007/s11060-021-03870.
    PubMed     Abstract available


  2. FANG S, Liang Y, Li L, Wang L, et al
    Correction to: Tumor location-based classification of surgery-related language impairments in patients with glioma.
    J Neurooncol. 2021 Oct 12. pii: 10.1007/s11060-021-03871.
    PubMed    


  3. BARAK T, Vetsa S, Nadar A, Jin L, et al
    Surgical strategies for older patients with glioblastoma.
    J Neurooncol. 2021 Oct 9. pii: 10.1007/s11060-021-03862.
    PubMed     Abstract available


  4. AKMAL S, Ginalis EE, Patel NV, Aiken R, et al
    Leptomeningeal disease in glioblastoma: endgame or opportunity?
    J Neurooncol. 2021 Oct 8. pii: 10.1007/s11060-021-03864.
    PubMed     Abstract available


  5. RINCON-TORROELLA J, Khela H, Bettegowda A, Bettegowda C, et al
    Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients.
    J Neurooncol. 2021 Oct 6. pii: 10.1007/s11060-021-03837.
    PubMed     Abstract available


  6. PATEL NV, Wong T, Fralin SR, Li M, et al
    Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial.
    J Neurooncol. 2021 Oct 3. pii: 10.1007/s11060-021-03851.
    PubMed     Abstract available


  7. ALDRICH KD, Horne VE, Bielamowicz K, Sonabend RY, et al
    Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
    J Neurooncol. 2021 Oct 1. pii: 10.1007/s11060-021-03847.
    PubMed     Abstract available


  8. FANG S, Liang Y, Li L, Wang L, et al
    Tumor location-based classification of surgery-related language impairments in patients with glioma.
    J Neurooncol. 2021 Oct 1. pii: 10.1007/s11060-021-03858.
    PubMed     Abstract available


  9. ORT J, Hamou HA, Kernbach JM, Hakvoort K, et al
    (18)F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection.
    J Neurooncol. 2021 Oct 1. pii: 10.1007/s11060-021-03844.
    PubMed     Abstract available


    September 2021
  10. FUJITA Y, Nagashima H, Tanaka K, Hashiguchi M, et al
    Hyperintense signal on diffusion-weighted imaging for monitoring the acute response and local recurrence after photodynamic therapy in malignant gliomas.
    J Neurooncol. 2021 Sep 22. pii: 10.1007/s11060-021-03845.
    PubMed     Abstract available


  11. CACHO-DIAZ B, Cuapatencatl LD, Rodriguez JA, Garcilazo-Reyes YJ, et al
    Identification of a high-risk group for brain metastases in non-small cell lung cancer patients.
    J Neurooncol. 2021 Sep 21. pii: 10.1007/s11060-021-03849.
    PubMed     Abstract available


  12. ROGERS S, Stauffer A, Lomax N, Alonso S, et al
    Five fraction stereotactic radiotherapy after brain metastasectomy: a single-institution experience and literature review.
    J Neurooncol. 2021 Sep 21. pii: 10.1007/s11060-021-03840.
    PubMed     Abstract available


  13. CARDONA AF, Jaramillo-Velasquez D, Ruiz-Patino A, Polo C, et al
    Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
    J Neurooncol. 2021 Sep 9. pii: 10.1007/s11060-021-03834.
    PubMed     Abstract available


  14. BARONI LV, Freytes C, Fernandez Ponce N, Oller A, et al
    Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma.
    J Neurooncol. 2021 Sep 9. pii: 10.1007/s11060-021-03842.
    PubMed     Abstract available


  15. DICPINIGAITIS AJ, Kazim SF, Schmidt MH, Couldwell WT, et al
    Association of baseline frailty status and age with postoperative morbidity and mortality following intracranial meningioma resection.
    J Neurooncol. 2021 Sep 8. pii: 10.1007/s11060-021-03841.
    PubMed     Abstract available


  16. BRAUN SE, Aslanzadeh FJ, Lanoye A, Fountain-Zaragoza S, et al
    Working memory training for adult glioma patients: a proof-of-concept study.
    J Neurooncol. 2021 Sep 7. pii: 10.1007/s11060-021-03839.
    PubMed     Abstract available


  17. VAN DER LINDEN SD, Rutten GM, Dirven L, Taphoorn MJB, et al
    eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial.
    J Neurooncol. 2021 Sep 6. pii: 10.1007/s11060-021-03828.
    PubMed     Abstract available


  18. PENG G, Su J, Xiao S, Liu Q, et al
    LINC00152 acts as a potential marker in gliomas and promotes tumor proliferation and invasion through the LINC00152/miR-107/RAB10 axis.
    J Neurooncol. 2021 Sep 3. pii: 10.1007/s11060-021-03836.
    PubMed     Abstract available


  19. LUO T, Ding K, Ji J, Zhang X, et al
    Cytoskeleton-associated protein 4 (CKAP4) promotes malignant progression of human gliomas through inhibition of the Hippo signaling pathway.
    J Neurooncol. 2021 Sep 2. pii: 10.1007/s11060-021-03831.
    PubMed     Abstract available


  20. AHMETI H, Borzikowsky C, Hollander D, Rocken C, et al
    Risks and neurological benefits of meningioma surgery in elderly patients compared to young patients.
    J Neurooncol. 2021 Sep 1. pii: 10.1007/s11060-021-03832.
    PubMed     Abstract available


  21. NORMAN S, Ramos A, Giantini Larsen AM, Bander E, et al
    Impact of the COVID-19 pandemic on neuro-oncology outcomes.
    J Neurooncol. 2021;154:375-381.
    PubMed     Abstract available


    August 2021
  22. PERAGALLO JH, Bruce BB, Vasseneix C, Jariyakosol S, et al
    Vision-related quality-of-life in pediatric primary brain tumor patients.
    J Neurooncol. 2021 Aug 30. pii: 10.1007/s11060-021-03835.
    PubMed     Abstract available


  23. NOFFSINGER B, Witter A, Sheybani N, Xiao A, et al
    Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner.
    J Neurooncol. 2021 Aug 25. pii: 10.1007/s11060-021-03822.
    PubMed     Abstract available


  24. SEARS TK, Horbinski CM, Woolard KD
    IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat.
    J Neurooncol. 2021 Aug 23. pii: 10.1007/s11060-021-03829.
    PubMed     Abstract available


  25. APRA C, Guillemot D, Frouin E, Bouvier C, et al
    Molecular description of meningeal solitary fibrous tumors/hemangiopericytomas compared to meningiomas: two completely separate entities.
    J Neurooncol. 2021 Aug 20. pii: 10.1007/s11060-021-03830.
    PubMed     Abstract available


  26. XIAO B, Lv SG, Wu MJ, Shen XL, et al
    Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p/HMGB3 axis.
    J Neurooncol. 2021 Aug 6. pii: 10.1007/s11060-021-03814.
    PubMed     Abstract available


  27. JIN L, Youngblood MW, Gupte TP, Vetsa S, et al
    Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.
    J Neurooncol. 2021 Aug 4. pii: 10.1007/s11060-021-03819.
    PubMed     Abstract available


  28. SCHNEIDER M, Schafer N, Apallas S, Potthoff AL, et al
    Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastoma.
    J Neurooncol. 2021 Aug 4. pii: 10.1007/s11060-021-03817.
    PubMed     Abstract available


    July 2021
  29. TAKIGAWA K, Hata N, Michiwaki Y, Hiwatashi A, et al
    Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma.
    J Neurooncol. 2021 Jul 28. pii: 10.1007/s11060-021-03812.
    PubMed     Abstract available


  30. LIN MR, Chen PY, Wang HC, Lin PC, et al
    Prevalence of sleep disturbances and their effects on quality of life in adults with untreated pituitary tumor and meningioma.
    J Neurooncol. 2021 Jul 24. pii: 10.1007/s11060-021-03811.
    PubMed     Abstract available


  31. OGINO A, Niranjan A, Kano H, Flickinger JC, et al
    Optimizing stereotactic radiosurgery in patients with recurrent or residual craniopharyngiomas.
    J Neurooncol. 2021 Jul 20. pii: 10.1007/s11060-021-03806.
    PubMed     Abstract available


  32. LEE EJ, Choi KS, Park ES, Cho YH, et al
    Single- and hypofractionated stereotactic radiosurgery for large (> 2 cm) brain metastases: a systematic review.
    J Neurooncol. 2021 Jul 15. pii: 10.1007/s11060-021-03805.
    PubMed     Abstract available


  33. BUNEVICIUS A, Pikis S, Padilla F, Prada F, et al
    Sonodynamic therapy for gliomas.
    J Neurooncol. 2021 Jul 12. pii: 10.1007/s11060-021-03807.
    PubMed     Abstract available


  34. PALMISCIANO P, Haider AS, Nwagwu CD, Wahood W, et al
    Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis.
    J Neurooncol. 2021 Jul 3. pii: 10.1007/s11060-021-03802.
    PubMed     Abstract available


  35. LIU IC, Holtzman AL, Rotondo RL, Indelicato DJ, et al
    Correction to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
    J Neurooncol. 2021 Jul 1. pii: 10.1007/s11060-021-03798.
    PubMed    


  36. VAN OPIJNEN MP, van der Meer PB, Dirven L, Fiocco M, et al
    The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
    J Neurooncol. 2021 Jul 1. pii: 10.1007/s11060-021-03800.
    PubMed     Abstract available


  37. MEHTA GU, Barone AK, Bradford D, Larkins E, et al
    US Food and Drug Administration regulatory updates in neuro-oncology.
    J Neurooncol. 2021;153:375-381.
    PubMed     Abstract available


    June 2021
  38. AHN SS, An C, Park YW, Han K, et al
    Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma.
    J Neurooncol. 2021 Jun 30. pii: 10.1007/s11060-021-03801.
    PubMed     Abstract available


  39. MAREIKE M, Franziska SB, Julia E, Daniel H, et al
    Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
    J Neurooncol. 2021 Jun 29. pii: 10.1007/s11060-021-03794.
    PubMed     Abstract available


  40. VAN RUITENBEEK NJ, Ho VKY, Westgeest HM, Beerepoot LV, et al
    Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery.
    J Neurooncol. 2021 Jun 25. pii: 10.1007/s11060-021-03793.
    PubMed     Abstract available


  41. PORPER K, Shpatz Y, Plotkin L, Pechthold RG, et al
    A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma.
    J Neurooncol. 2021 Jun 21. pii: 10.1007/s11060-021-03786.
    PubMed     Abstract available


  42. CHO A, Untersteiner H, Fitschek F, Khalaveh F, et al
    The clinical relevance of laboratory prognostic scores for patients with radiosurgically treated brain metastases of non-pulmonary primary tumor.
    J Neurooncol. 2021 Jun 20. pii: 10.1007/s11060-021-03788.
    PubMed     Abstract available


  43. BETTAG C, Hussein A, Sachkova A, Bock HC, et al
    Implantation of Carmustine wafers after resection of malignant glioma with and without opening of the ventricular system.
    J Neurooncol. 2021 Jun 20. pii: 10.1007/s11060-021-03792.
    PubMed     Abstract available


  44. NEWMAN WC, Goldberg J, Guadix SW, Brown S, et al
    The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes.
    J Neurooncol. 2021 Jun 19. pii: 10.1007/s11060-021-03790.
    PubMed     Abstract available


  45. ROSSO DA, Rosato M, Iturrizaga J, Gonzalez N, et al
    Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated gammadelta T lymphocytes.
    J Neurooncol. 2021 Jun 14. pii: 10.1007/s11060-021-03787.
    PubMed     Abstract available


  46. LIU IH, Holtzman AL, Rotondo RL, Indelicato DJ, et al
    Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
    J Neurooncol. 2021 Jun 8. pii: 10.1007/s11060-021-03783.
    PubMed     Abstract available


  47. CASTRO M, Pampana A, Alam A, Parashar R, et al
    Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit.
    J Neurooncol. 2021 Jun 8. pii: 10.1007/s11060-021-03780.
    PubMed     Abstract available


  48. CHEN YL, Huang AP, Wang CC, Chen HY, et al
    Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasis.
    J Neurooncol. 2021 Jun 7. pii: 10.1007/s11060-021-03782.
    PubMed     Abstract available


  49. ADELON J, Dufour C, Foulon S, Masliah Planchon J, et al
    What does a non-response to induction chemotherapy imply in high-risk medulloblastomas?
    J Neurooncol. 2021 Jun 2. pii: 10.1007/s11060-021-03777.
    PubMed     Abstract available


    May 2021
  50. EICHBERG DG, Slepak TI, Pascoini AL, Komotar RJ, et al
    Genetic manipulation of adhesion GPCR CD97/ADGRE5 modulates invasion in patient-derived glioma stem cells.
    J Neurooncol. 2021 May 24. pii: 10.1007/s11060-021-03778.
    PubMed     Abstract available


  51. DIJKSTRA BM, de Jong M, Stroet MCM, Andreae F, et al
    Correction to: Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.
    J Neurooncol. 2021 May 20. pii: 10.1007/s11060-021-03769.
    PubMed    


  52. MOTOMURA K, Chalise L, Ohka F, Aoki K, et al
    Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping.
    J Neurooncol. 2021 May 19. pii: 10.1007/s11060-021-03776.
    PubMed     Abstract available


  53. OYA S, Ikawa F, Ichihara N, Wanibuchi M, et al
    Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan.
    J Neurooncol. 2021 May 17. pii: 10.1007/s11060-021-03775.
    PubMed     Abstract available


  54. ZHONG J, Huang V, Gurbani SS, Ramesh K, et al
    3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas.
    J Neurooncol. 2021 May 13. pii: 10.1007/s11060-021-03770.
    PubMed     Abstract available


  55. FATIMA N, Shin JH, Curry WT, Chang SD, et al
    Microsurgical resection of foramen magnum meningioma: multi-institutional retrospective case series and proposed surgical risk scoring system.
    J Neurooncol. 2021 May 10. pii: 10.1007/s11060-021-03773.
    PubMed     Abstract available


  56. KRAUSS WE, Yolcu YU, Alvi MA, Moinuddin FM, et al
    Clinical characteristics and management differences for grade II and III spinal meningiomas.
    J Neurooncol. 2021 May 10. pii: 10.1007/s11060-021-03771.
    PubMed     Abstract available


  57. CROTTY EE, Smith SMC, Brasel K, Pakiam F, et al
    Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
    J Neurooncol. 2021 May 8. pii: 10.1007/s11060-021-03767.
    PubMed     Abstract available


  58. EL-KHOULY FE, Veldhuijzen van Zanten SEM, Jansen MHA, Bakker DP, et al
    A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.
    J Neurooncol. 2021 May 7. pii: 10.1007/s11060-021-03763.
    PubMed     Abstract available


  59. CORONA AM, Di L, Shah AH, Crespo R, et al
    Current experimental therapies for atypical and malignant meningiomas.
    J Neurooncol. 2021 May 5. pii: 10.1007/s11060-021-03759.
    PubMed     Abstract available


  60. RUTTENS D, Messiaen J, Ferster A, Piette C, et al
    Retrospective study of diffuse intrinsic pontine glioma in the Belgian population: a 25 year experience.
    J Neurooncol. 2021 May 3. pii: 10.1007/s11060-021-03766.
    PubMed     Abstract available


    April 2021
  61. DASGUPTA A, Geraghty B, Maralani PJ, Malik N, et al
    Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema.
    J Neurooncol. 2021 Apr 27. pii: 10.1007/s11060-021-03762.
    PubMed     Abstract available


  62. AVADIAPPAN S, Morrison MA, Jakary A, Felton E, et al
    Relationship between 7T MR-angiography features of vascular injury and cognitive decline in young brain tumor patients treated with radiation therapy.
    J Neurooncol. 2021 Apr 24. pii: 10.1007/s11060-021-03753.
    PubMed     Abstract available


  63. SONG J, Aljabab S, Abduljabbar L, Tseng YD, et al
    Radiation-induced brain injury in patients with meningioma treated with proton or photon therapy.
    J Neurooncol. 2021 Apr 22. pii: 10.1007/s11060-021-03758.
    PubMed     Abstract available


  64. GILLESPIE CS, Islim AI, Taweel BA, Millward CP, et al
    The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring.
    J Neurooncol. 2021 Apr 22. pii: 10.1007/s11060-021-03761.
    PubMed     Abstract available


  65. DONO A, Mitra S, Shah M, Takayasu T, et al
    PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.
    J Neurooncol. 2021 Apr 21. pii: 10.1007/s11060-021-03755.
    PubMed     Abstract available


  66. CHO YA, Kim D, Lee B, Shim JH, et al
    Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.
    J Neurooncol. 2021 Apr 17. pii: 10.1007/s11060-021-03710.
    PubMed     Abstract available


  67. O'KEEFFE D, Bambury RM, O'Reilly S
    High grade glioma and caregiver burden.
    J Neurooncol. 2021 Apr 15. pii: 10.1007/s11060-021-03754.
    PubMed    


  68. SCHEURING UJ, Ritter S, Martin D, Schackert G, et al
    GliPR1 knockdown by RNA interference exerts anti-glioma effects in vitro and in vivo.
    J Neurooncol. 2021 Apr 15. pii: 10.1007/s11060-021-03737.
    PubMed     Abstract available


  69. RUSTE V, Sunyach MP, Tanguy R, Jouanneau E, et al
    Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screening.
    J Neurooncol. 2021 Apr 10. pii: 10.1007/s11060-021-03751.
    PubMed     Abstract available


  70. VAN DER MEER PB, Koekkoek JAF, van den Bent MJ, Dirven L, et al
    Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints.
    J Neurooncol. 2021 Apr 6. pii: 10.1007/s11060-021-03747.
    PubMed     Abstract available


  71. RUTENBERG MS, Rotondo RL, Rao D, Holtzman AL, et al
    Correction to: Clinical outcomes following proton therapy for adult craniopharyngioma: a singleinstitution cohort study.
    J Neurooncol. 2021;152:415.
    PubMed    


    March 2021
  72. BRENNAN PM, Borchert R, Coulter C, Critchley GR, et al
    Second surgery for progressive glioblastoma: a multi-centre questionnaire and cohort-based review of clinical decision-making and patient outcomes in current practice.
    J Neurooncol. 2021 Mar 31. pii: 10.1007/s11060-021-03748.
    PubMed     Abstract available


  73. LE VAN T, Graillon T, Jacob J, Vauleon E, et al
    Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort.
    J Neurooncol. 2021 Mar 28. pii: 10.1007/s11060-021-03741.
    PubMed     Abstract available


  74. MARTINEZ-PEREZ R, Florez-Perdomo W, Freeman L, Ung TH, et al
    Long-term disease control and treatment outcomes of stereotactic radiosurgery in cavernous sinus meningiomas.
    J Neurooncol. 2021 Mar 27. pii: 10.1007/s11060-021-03732.
    PubMed     Abstract available


  75. DIJKSTRA BM, de Jong M, Stroet MCM, Andreae F, et al
    Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.
    J Neurooncol. 2021 Mar 26. pii: 10.1007/s11060-021-03739.
    PubMed     Abstract available


  76. ARUN S, Ravisankar S, Vanisree AJ
    Correction to: Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc.
    J Neurooncol. 2021 Mar 24. pii: 10.1007/s11060-021-03743.
    PubMed    


  77. OSTROM QT, Krebs HL, Patil N, Cioffi G, et al
    Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US.
    J Neurooncol. 2021 Mar 23. pii: 10.1007/s11060-021-03736.
    PubMed     Abstract available


  78. RITTERBUSCH R, Halasz LM, Graber JJ
    Distinct imaging patterns of pseudoprogression in glioma patients following proton versus photon radiation therapy.
    J Neurooncol. 2021 Mar 22. pii: 10.1007/s11060-021-03734.
    PubMed     Abstract available


  79. TABOR JK, Bonda D, LeMonda BC, D'Amico RS, et al
    Neuropsychological outcomes following supratotal resection for high-grade glioma: a review.
    J Neurooncol. 2021 Mar 21. pii: 10.1007/s11060-021-03731.
    PubMed     Abstract available


  80. VERMANDEL M, Dupont C, Lecomte F, Leroy HA, et al
    Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial.
    J Neurooncol. 2021 Mar 20. pii: 10.1007/s11060-021-03718.
    PubMed     Abstract available


  81. FULBERT C, Chabardes S, Ratel D
    Adjuvant therapeutic potential of moderate hypothermia for glioblastoma.
    J Neurooncol. 2021 Mar 19. pii: 10.1007/s11060-021-03704.
    PubMed     Abstract available


  82. MILLS MN, Thawani C, Figura NB, Oliver DE, et al
    Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases.
    J Neurooncol. 2021 Mar 19. pii: 10.1007/s11060-021-03735.
    PubMed     Abstract available


  83. SHIRVALILOU S, Khoei S, Esfahani AJ, Kamali M, et al
    Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review.
    J Neurooncol. 2021 Mar 13. pii: 10.1007/s11060-021-03729.
    PubMed     Abstract available


  84. MALLA RR, Gopinath S, Gondi CS, Alapati K, et al
    Retraction Note to: uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.
    J Neurooncol. 2021 Mar 12. pii: 10.1007/s11060-021-03722.
    PubMed    


  85. TATEKAWA H, Uetani H, Hagiwara A, Yao J, et al
    Preferential tumor localization in relation to (18)F-FDOPA uptake for lower-grade gliomas.
    J Neurooncol. 2021 Mar 11. pii: 10.1007/s11060-021-03730.
    PubMed     Abstract available


  86. NAUNG H, Cohen KJ
    An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity.
    J Neurooncol. 2021 Mar 10. pii: 10.1007/s11060-021-03727.
    PubMed     Abstract available


  87. AHN J, Bunevicius A, Sheehan J
    Spontaneous pneumocephalus associated with a melanoma brain metastasis: a Case Report.
    J Neurooncol. 2021 Mar 9. pii: 10.1007/s11060-021-03728.
    PubMed    


  88. BURTH S, Ohmann M, Kronsteiner D, Kieser M, et al
    Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?
    J Neurooncol. 2021 Mar 5. pii: 10.1007/s11060-021-03716.
    PubMed     Abstract available


  89. PATEL SH, Batchala PP, Muttikkal TJE, Ferrante SS, et al
    Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.
    J Neurooncol. 2021 Mar 4. pii: 10.1007/s11060-021-03720.
    PubMed     Abstract available


  90. KURDI M, Butt NS, Baeesa S, Alghamdi B, et al
    Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies.
    J Neurooncol. 2021 Mar 4. pii: 10.1007/s11060-021-03723.
    PubMed     Abstract available


  91. MAIR MJ, Kiesel B, Feldmann K, Widhalm G, et al
    LAG-3 expression in the inflammatory microenvironment of glioma.
    J Neurooncol. 2021 Mar 2. pii: 10.1007/s11060-021-03721.
    PubMed     Abstract available


  92. LIM-FAT MJ, Song KW, Iorgulescu JB, Andersen BM, et al
    Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.
    J Neurooncol. 2021 Mar 1. pii: 10.1007/s11060-021-03719.
    PubMed     Abstract available


    February 2021
  93. UNTERBERGER A, Nguyen T, Duong C, Kondajji A, et al
    Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
    J Neurooncol. 2021 Feb 26. pii: 10.1007/s11060-020-03674.
    PubMed     Abstract available


  94. KRAFT J, Mayinger M, Willmann J, Brown M, et al
    Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology.
    J Neurooncol. 2021 Feb 23. pii: 10.1007/s11060-021-03714.
    PubMed     Abstract available


  95. MOMIN AA, Shao J, Soni P, Almeida JP, et al
    Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study.
    J Neurooncol. 2021 Feb 15. pii: 10.1007/s11060-021-03711.
    PubMed     Abstract available


  96. HOLUB K, Louvel G
    Poor performance status and brain metastases treatment: who may benefit from the stereotactic radiotherapy?
    J Neurooncol. 2021 Feb 15. pii: 10.1007/s11060-021-03712.
    PubMed     Abstract available


  97. CIFARELLI CP, Jacques A, Bobko A
    Heterogeneity of radiation response in mesenchymal subtype glioblastoma: molecular profiling and reactive oxygen species generation.
    J Neurooncol. 2021 Feb 10. pii: 10.1007/s11060-021-03707.
    PubMed     Abstract available


  98. BORGER V, Hamed M, Ilic I, Potthoff AL, et al
    Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection.
    J Neurooncol. 2021 Feb 7. pii: 10.1007/s11060-021-03705.
    PubMed     Abstract available


  99. PRZYBYLOWSKI CJ, Hervey-Jumper SL, Sanai N
    Surgical strategy for insular glioma.
    J Neurooncol. 2021;151:491-497.
    PubMed     Abstract available


  100. ROGERS CM, Jones PS, Weinberg JS
    Intraoperative MRI for Brain Tumors.
    J Neurooncol. 2021;151:479-490.
    PubMed     Abstract available


  101. KARIMI S, Mansouri S, Nassiri F, Bunda S, et al
    Clinical significance of checkpoint regulator "Programmed death ligand-1 (PD-L1)" expression in meningioma: review of the current status.
    J Neurooncol. 2021;151:443-449.
    PubMed     Abstract available


  102. D'AMICO RS, Aghi MK, Vogelbaum MA, Bruce JN, et al
    Convection-enhanced drug delivery for glioblastoma: a review.
    J Neurooncol. 2021;151:415-427.
    PubMed     Abstract available


  103. HOLLON T, Orringer DA
    Label-free brain tumor imaging using Raman-based methods.
    J Neurooncol. 2021;151:393-402.
    PubMed     Abstract available


  104. CHAN HY, Choi J, Jackson C, Lim M, et al
    Combination immunotherapy strategies for glioblastoma.
    J Neurooncol. 2021;151:375-391.
    PubMed     Abstract available


    January 2021
  105. VAIDYA KS, Mitten MJ, Zelaya-Lazo AL, Oleksijew A, et al
    Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR.
    J Neurooncol. 2021 Jan 30. pii: 10.1007/s11060-021-03703.
    PubMed     Abstract available


  106. MEDIKONDA R, Srivastava S, Kim T, Xia Y, et al
    Development of new brain metastases in triple negative breast cancer.
    J Neurooncol. 2021 Jan 29. pii: 10.1007/s11060-021-03702.
    PubMed     Abstract available


  107. KOMMERS I, Ackermans L, Ardon H, van den Brink WA, et al
    Between-hospital variation in rates of complications and decline of patient performance after glioblastoma surgery in the dutch Quality Registry Neuro Surgery.
    J Neurooncol. 2021 Jan 28. pii: 10.1007/s11060-021-03697.
    PubMed     Abstract available


  108. SAUNDERS JT, Holmes B, Benavides-Serrato A, Kumar S, et al
    Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.
    J Neurooncol. 2021 Jan 28. pii: 10.1007/s11060-021-03699.
    PubMed     Abstract available


  109. KEBIR S, Rauschenbach L, Weber M, Lazaridis L, et al
    Machine learning-based differentiation between multiple sclerosis and glioma WHO II degrees -IV degrees using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.
    J Neurooncol. 2021 Jan 27. pii: 10.1007/s11060-021-03701.
    PubMed     Abstract available


  110. DONO A, Amsbaugh M, Martir M, Smilie RH, et al
    Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma.
    J Neurooncol. 2021 Jan 25. pii: 10.1007/s11060-020-03689.
    PubMed     Abstract available


  111. BU L, Hameed NUF, Luo C, Hong P, et al
    Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma.
    J Neurooncol. 2021 Jan 24. pii: 10.1007/s11060-020-03676.
    PubMed     Abstract available


  112. SHARMA A, Fruth B, Barrera C, Farfour HN, et al
    How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians.
    J Neurooncol. 2021 Jan 23. pii: 10.1007/s11060-021-03700.
    PubMed     Abstract available


  113. PATRIZZ A, Dono A, Zhu P, Tandon N, et al
    Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?
    J Neurooncol. 2021 Jan 22. pii: 10.1007/s11060-020-03690.
    PubMed     Abstract available


  114. HAEREN RHL, Rautalin I, Schwartz C, Korja M, et al
    Surgery on giant meningiomas in very old patients entails frequent postoperative intracranial hemorrhages and atypical histopathology.
    J Neurooncol. 2021 Jan 21. pii: 10.1007/s11060-020-03693.
    PubMed     Abstract available


  115. MALAIZE H, Samoyeau T, Zanello M, Roux A, et al
    Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience.
    J Neurooncol. 2021 Jan 15. pii: 10.1007/s11060-021-03696.
    PubMed     Abstract available


  116. WEGNER RE, Abel S, D'Amico RS, Mehta GU, et al
    Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome.
    J Neurooncol. 2021 Jan 11. pii: 10.1007/s11060-020-03663.
    PubMed     Abstract available


  117. NOWAK-CHOI K, Palmer JD, Casey J, Chitale A, et al
    Resected WHO grade I meningioma and predictors of local control.
    J Neurooncol. 2021 Jan 9. pii: 10.1007/s11060-020-03688.
    PubMed     Abstract available


  118. FUJIOKA Y, Hata N, Akagi Y, Kuga D, et al
    Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
    J Neurooncol. 2021 Jan 8. pii: 10.1007/s11060-020-03682.
    PubMed     Abstract available


  119. ZHANG M, Rodrigues AJ, Pollom EL, Gibbs IC, et al
    Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
    J Neurooncol. 2021 Jan 7. pii: 10.1007/s11060-020-03686.
    PubMed     Abstract available


  120. GOMES I, Moreno DA, Dos Reis MB, da Silva LS, et al
    Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide.
    J Neurooncol. 2021 Jan 5. pii: 10.1007/s11060-020-03675.
    PubMed     Abstract available


  121. SHI W, Blumenthal DT, Bush NAO, Kebir S, et al
    Correction to: Global postmarketing safety surveillance of Tumor Treating Fields (TTFields) in patients with highgrade glioma in clinical practice.
    J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03681.
    PubMed    


  122. OLIVA MA, Staffieri S, Castaldo S, Giangaspero F, et al
    Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours.
    J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03673.
    PubMed     Abstract available


  123. BRAHMBHATT N, Stupp R, Bushara O, Bachman E, et al
    Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy.
    J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03664.
    PubMed     Abstract available


  124. WUMMER B, Woodworth D, Flores C
    Brain stem gliomas and current landscape.
    J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03655.
    PubMed     Abstract available


  125. HABIB A, Pease M, Kodavali CV, Amankulor N, et al
    A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care.
    J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03671.
    PubMed     Abstract available


  126. CHAMPEAUX-DEPOND C, Weller J, Froelich S, Sartor A, et al
    Cyproterone acetate and meningioma: a nationwide-wide population based study.
    J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03672.
    PubMed     Abstract available


  127. CLAVREUL A, Aubin G, Delion M, Lemee JM, et al
    What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?
    J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03666.
    PubMed     Abstract available


  128. VANMARCKE D, Menten J, Defraene G, Van Calenbergh F, et al
    Stroke rate after external fractionated radiotherapy for benign meningioma.
    J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03678.
    PubMed     Abstract available


  129. SAMARUT E, Lugat A, Amelot A, Scharbarg E, et al
    Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma.
    J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03683.
    PubMed     Abstract available


  130. NIMBALKAR VP, Kruthika BS, Sravya P, Rao S, et al
    Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
    J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03685.
    PubMed     Abstract available


  131. BUNK EC, Wagner A, Stummer W, Senner V, et al
    5-ALA kinetics in meningiomas: analysis of tumor fluorescence and PpIX metabolism in vitro and comparative analyses with high-grade gliomas.
    J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03680.
    PubMed     Abstract available


  132. HADDAD AF, Young JS, Mummaneni NV, Kasahara N, et al
    Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies.
    J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03684.
    PubMed     Abstract available


  133. LEE D, Riestenberg RA, Haskell-Mendoza A, Bloch O, et al
    Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review.
    J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03677.
    PubMed     Abstract available


    November 2020
  134. FAN KY, Lalani N, LeVasseur N, Krauze A, et al
    Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy.
    J Neurooncol. 2020 Nov 18. pii: 10.1007/s11060-020-03657.
    PubMed     Abstract available


  135. POETSCH L, Bronnimann C, Loiseau H, Frenel JS, et al
    Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.
    J Neurooncol. 2020 Nov 17. pii: 10.1007/s11060-020-03662.
    PubMed     Abstract available


  136. SONI P, Davison MA, Shao J, Momin A, et al
    Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
    J Neurooncol. 2020 Nov 17. pii: 10.1007/s11060-020-03632.
    PubMed     Abstract available


  137. CHAN RW, Chen H, Myrehaug S, Atenafu EG, et al
    Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.
    J Neurooncol. 2020 Nov 16. pii: 10.1007/s11060-020-03661.
    PubMed     Abstract available


  138. CHO A, Untersteiner H, Hirschmann D, Fitschek F, et al
    Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients.
    J Neurooncol. 2020 Nov 11. pii: 10.1007/s11060-020-03660.
    PubMed     Abstract available


  139. NAKADA M, Nakajima R, Okita H, Nakade Y, et al
    Awake surgery for right frontal lobe glioma can preserve visuospatial cognition and spatial working memory.
    J Neurooncol. 2020 Nov 2. pii: 10.1007/s11060-020-03656.
    PubMed     Abstract available


  140. FARRELL C, Shi W, Bodman A, Olson JJ, et al
    Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
    J Neurooncol. 2020;150:269-359.
    PubMed     Abstract available


  141. ZIU M, Kim BYS, Jiang W, Ryken T, et al
    The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol. 2020;150:215-267.
    PubMed     Abstract available


  142. REDJAL N, Nahed BV, Dietrich J, Kalkanis SN, et al
    Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults.
    J Neurooncol. 2020;150:165-213.
    PubMed     Abstract available


  143. VELAZQUEZ VEGA JE, Brat DJ, Ryken TC, Olson JJ, et al
    The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol. 2020;150:143-164.
    PubMed     Abstract available


  144. DOMINO JS, Ormond DR, Germano IM, Sami M, et al
    Cytoreductive surgery in the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol. 2020;150:121-142.
    PubMed     Abstract available


  145. LUNDY P, Domino J, Ryken T, Fouke S, et al
    The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol. 2020;150:95-120.
    PubMed     Abstract available


  146. OLSON JJ, Ryken TC
    Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.
    J Neurooncol. 2020;150:87-93.
    PubMed     Abstract available


    October 2020
  147. CHANG L, Wang J, Zhou F, Wang D, et al
    LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
    J Neurooncol. 2020 Oct 30. pii: 10.1007/s11060-020-03624.
    PubMed     Abstract available


  148. RAHMAN M, Parney I
    Journal of Neuro Oncology: immunotherapy for brain tumors.
    J Neurooncol. 2020 Oct 20. pii: 10.1007/s11060-020-03589.
    PubMed    


  149. ZAMANIPOOR NAJAFABADI AH, van der Meer PB, Boele FW, Taphoorn MJB, et al
    Determinants and predictors for the long-term disease burden of intracranial meningioma patients.
    J Neurooncol. 2020 Oct 19. pii: 10.1007/s11060-020-03650.
    PubMed     Abstract available


  150. HE W, Liu Z, Teng H, Tang L, et al
    Pediatric meningiomas: 10-year experience with 39 patients.
    J Neurooncol. 2020 Oct 16. pii: 10.1007/s11060-020-03649.
    PubMed     Abstract available


  151. MCABEE JH, Degorre-Kerbaul C, Valdez K, Wendler A, et al
    Detection of glioblastoma intratumor heterogeneity in radiosensitivity using patient-derived neurosphere cultures.
    J Neurooncol. 2020 Oct 15. pii: 10.1007/s11060-020-03643.
    PubMed     Abstract available


  152. HIPP SJ, Goldman S, Kaushal A, Krauze A, et al
    A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
    J Neurooncol. 2020 Oct 11. pii: 10.1007/s11060-020-03627.
    PubMed     Abstract available


  153. DEWIRE M, Fuller C, Hummel TR, Chow LML, et al
    A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    J Neurooncol. 2020 Oct 9. pii: 10.1007/s11060-020-03641.
    PubMed     Abstract available


  154. SONG Y, Hu Z, Long H, Peng Y, et al
    Correction to: A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.
    J Neurooncol. 2020 Oct 8. pii: 10.1007/s11060-020-03644.
    PubMed     Abstract available


  155. SELT F, van Tilburg CM, Bison B, Sievers P, et al
    Response to trametinib treatment in progressive pediatric low-grade glioma patients.
    J Neurooncol. 2020 Oct 7. pii: 10.1007/s11060-020-03640.
    PubMed     Abstract available


  156. MOROKOFF A, Jones J, Nguyen H, Ma C, et al
    Correction to: Serum microRNA is a biomarker for post-operative monitoring in glioma.
    J Neurooncol. 2020 Oct 7. pii: 10.1007/s11060-020-03630.
    PubMed     Abstract available


  157. DE TOMMASI C, Richardson E, Reale M, Jordan J, et al
    Evaluation of a novel application of a mindfulness phone application for patients with brain tumours: a feasibility study.
    J Neurooncol. 2020 Oct 6. pii: 10.1007/s11060-020-03638.
    PubMed     Abstract available


  158. DONO A, Vu J, Anapolsky M, Hines G, et al
    Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
    J Neurooncol. 2020 Oct 3. pii: 10.1007/s11060-020-03634.
    PubMed     Abstract available


    September 2020
  159. SCHNEIDER M, Ilic I, Potthoff AL, Hamed M, et al
    Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality rates.
    J Neurooncol. 2020 Sep 29. pii: 10.1007/s11060-020-03629.
    PubMed     Abstract available


  160. SCHNEIDER M, Potthoff AL, Scharnbock E, Heimann M, et al
    Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival.
    J Neurooncol. 2020 Sep 29. pii: 10.1007/s11060-020-03625.
    PubMed     Abstract available


  161. RAMOS-FRESNEDO A, Domingo RA, Vivas-Buitrago T, Lundy L, et al
    Multiple meningiomas: does quantity matter? a population-based survival analysis with underlined age and sex differences.
    J Neurooncol. 2020 Sep 28. pii: 10.1007/s11060-020-03620.
    PubMed     Abstract available


  162. DI PERRI D, Tanguy R, Malet C, Robert A, et al
    Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
    J Neurooncol. 2020 Sep 26. pii: 10.1007/s11060-020-03628.
    PubMed     Abstract available


  163. WEISS SA, Zito C, Tran T, Heishima K, et al
    Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
    J Neurooncol. 2020 Sep 24. pii: 10.1007/s11060-020-03619.
    PubMed     Abstract available


  164. KHALAFALLAH AM, Jimenez AE, Patel P, Huq S, et al
    A novel online calculator predicting short-term postoperative outcomes in patients with metastatic brain tumors.
    J Neurooncol. 2020 Sep 22. pii: 10.1007/s11060-020-03626.
    PubMed     Abstract available


  165. SENFT C, Behrens M, Lortz I, Wenger K, et al
    The ability to return to work: a patient-centered outcome parameter following glioma surgery.
    J Neurooncol. 2020 Sep 22. pii: 10.1007/s11060-020-03609.
    PubMed     Abstract available


  166. KHAN AB, Gadot R, Shetty A, Bayley JC 5th, et al
    Identification of novel fusion transcripts in meningioma.
    J Neurooncol. 2020 Sep 19. pii: 10.1007/s11060-020-03599.
    PubMed     Abstract available


  167. TATEKAWA H, Hagiwara A, Uetani H, Yao J, et al
    Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naive diffuse gliomas.
    J Neurooncol. 2020 Sep 14. pii: 10.1007/s11060-020-03613.
    PubMed     Abstract available


  168. MOROKOFF A, Jones J, Nguyen H, Ma C, et al
    Serum microRNA is a biomarker for post-operative monitoring in glioma.
    J Neurooncol. 2020 Sep 11. pii: 10.1007/s11060-020-03566.
    PubMed     Abstract available


  169. TENG CW, Amirshaghaghi A, Cho SS, Cai SS, et al
    Combined fluorescence-guided surgery and photodynamic therapy for glioblastoma multiforme using cyanine and chlorin nanocluster.
    J Neurooncol. 2020 Sep 10. pii: 10.1007/s11060-020-03618.
    PubMed     Abstract available


  170. TANG Z, Yang G, Wang X, Chen F, et al
    AKT/GSK-3beta/beta-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
    J Neurooncol. 2020 Sep 9. pii: 10.1007/s11060-020-03602.
    PubMed     Abstract available


  171. STAHL P, Fekete B, Henoch I, Smits A, et al
    Health-related quality of life and emotional well-being in patients with glioblastoma and their relatives.
    J Neurooncol. 2020 Sep 9. pii: 10.1007/s11060-020-03614.
    PubMed     Abstract available


  172. ALIOTTA E, Dutta SW, Feng X, Tustison NJ, et al
    Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign.
    J Neurooncol. 2020 Sep 9. pii: 10.1007/s11060-020-03611.
    PubMed     Abstract available


  173. HOLLINGWORTH MA, Zacharoulis S
    Development of a clinical scale for assessment of patients with diffuse intrinsic pontine glioma (DIPG) receiving experimental therapy: the PONScore.
    J Neurooncol. 2020 Sep 9. pii: 10.1007/s11060-020-03594.
    PubMed     Abstract available


  174. DUTTA SW, Mack ML, Aliotta E, Ward KA, et al
    Intracranial disease control for EGFR-mutant and ALK-rearranged lung cancer with large volume or symptomatic brain metastases.
    J Neurooncol. 2020 Sep 9. pii: 10.1007/s11060-020-03615.
    PubMed     Abstract available


    August 2020
  175. TSENG CL, Stewart J, Whitfield G, Verhoeff JJC, et al
    Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow.
    J Neurooncol. 2020 Aug 29. pii: 10.1007/s11060-020-03605.
    PubMed     Abstract available


  176. BROWN DA, Goyal A, Kerezoudis P, Alvi MA, et al
    Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
    J Neurooncol. 2020 Aug 28. pii: 10.1007/s11060-020-03604.
    PubMed     Abstract available


  177. HALTOM AR, Toll SA, Cheng D, Maegawa S, et al
    Medulloblastoma epigenetics and the path to clinical innovation.
    J Neurooncol. 2020 Aug 20. pii: 10.1007/s11060-020-03591.
    PubMed     Abstract available


  178. HOTCHKISS KM, Sampson JH
    Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor.
    J Neurooncol. 2020 Aug 19. pii: 10.1007/s11060-020-03598.
    PubMed     Abstract available


  179. ELLEAUME H, Barth RF, Rousseau J, Bobyk L, et al
    Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma.
    J Neurooncol. 2020 Aug 18. pii: 10.1007/s11060-020-03600.
    PubMed     Abstract available


  180. COONEY TM, Lubanszky E, Prasad R, Hawkins C, et al
    Diffuse midline glioma: review of epigenetics.
    J Neurooncol. 2020 Aug 17. pii: 10.1007/s11060-020-03553.
    PubMed     Abstract available


  181. VERMA BK, Kondaiah P
    Regulation of beta-catenin by IGFBP2 and its cytoplasmic actions in glioma.
    J Neurooncol. 2020 Aug 16. pii: 10.1007/s11060-020-03596.
    PubMed     Abstract available


  182. MANOHARAN N, Choi J, Chordas C, Zimmerman MA, et al
    Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma.
    J Neurooncol. 2020 Aug 11. pii: 10.1007/s11060-020-03592.
    PubMed     Abstract available


  183. SHIN DH, Melnick KF, Tran DD, Ghiaseddin AP, et al
    In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas.
    J Neurooncol. 2020 Aug 5. pii: 10.1007/s11060-020-03557.
    PubMed     Abstract available


  184. GRIPPIN AJ, Dyson KA, Qdaisat S, McGuiness J, et al
    Nanoparticles as immunomodulators and translational agents in brain tumors.
    J Neurooncol. 2020 Aug 5. pii: 10.1007/s11060-020-03559.
    PubMed     Abstract available


    July 2020
  185. LYNES J, Acquaye AA, Sur H, Nwankwo A, et al
    Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor Section.
    J Neurooncol. 2020 Jul 23. pii: 10.1007/s11060-020-03585.
    PubMed     Abstract available


  186. APRA C, Roblot P, Alkhayri A, Le Guerinel C, et al
    Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas.
    J Neurooncol. 2020 Jul 23. pii: 10.1007/s11060-020-03576.
    PubMed     Abstract available


  187. MIYATAKE SI, Wanibuchi M, Hu N, Ono K, et al
    Boron neutron capture therapy for malignant brain tumors.
    J Neurooncol. 2020 Jul 16. pii: 10.1007/s11060-020-03586.
    PubMed     Abstract available


  188. HAUSER BM, Gupta S, Xu E, Wu K, et al
    Impact of insurance on hospital course and readmission after resection of benign meningioma.
    J Neurooncol. 2020 Jul 11. pii: 10.1007/s11060-020-03581.
    PubMed     Abstract available


  189. BUTTERBROD E, Synhaeve N, Rutten GJ, Schwabe I, et al
    Cognitive impairment three months after surgery is an independent predictor of survival time in glioblastoma patients.
    J Neurooncol. 2020 Jul 8. pii: 10.1007/s11060-020-03577.
    PubMed     Abstract available


  190. AKERET K, Staartjes VE, Vasella F, Serra C, et al
    Distinct topographic-anatomical patterns in primary and secondary brain tumors and their therapeutic potential.
    J Neurooncol. 2020 Jul 8. pii: 10.1007/s11060-020-03574.
    PubMed     Abstract available


  191. FONSECA A, Afzal S, Bowes L, Crooks B, et al
    Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
    J Neurooncol. 2020 Jul 7. pii: 10.1007/s11060-020-03568.
    PubMed     Abstract available


  192. CLIMANS SA, Brandes AA, Cairncross JG, Ding K, et al
    Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients.
    J Neurooncol. 2020 Jul 6. pii: 10.1007/s11060-020-03573.
    PubMed     Abstract available


  193. SHAH AH, Mahavadi A, Di L, Sanjurjo A, et al
    Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.
    J Neurooncol. 2020 Jul 5. pii: 10.1007/s11060-020-03541.
    PubMed     Abstract available


  194. LIU EK, Yu S, Sulman EP, Kurz SC, et al
    Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma.
    J Neurooncol. 2020 Jul 2. pii: 10.1007/s11060-020-03572.
    PubMed     Abstract available


  195. CHOQUE-VELASQUEZ J, Resendiz-Nieves J, Jahromi BR, Baluszek S, et al
    Long-term survival outcomes of pineal region gliomas.
    J Neurooncol. 2020 Jul 1. pii: 10.1007/s11060-020-03571.
    PubMed     Abstract available


  196. OH HJ, Cho YH, Kim JH, Kim CJ, et al
    Hypofractionated stereotactic radiosurgery for large-sized skull base meningiomas.
    J Neurooncol. 2020 Jul 1. pii: 10.1007/s11060-020-03575.
    PubMed     Abstract available


    June 2020
  197. SUJIJANTARAT N, Hong CS, Owusu KA, Elsamadicy AA, et al
    Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases.
    J Neurooncol. 2020 Jun 29. pii: 10.1007/s11060-020-03570.
    PubMed     Abstract available


  198. GATSON NTN, Bross SP, Odia Y, Mongelluzzo GJ, et al
    Early imaging marker of progressing glioblastoma: a window of opportunity.
    J Neurooncol. 2020 Jun 29. pii: 10.1007/s11060-020-03565.
    PubMed     Abstract available


  199. SHEE K, Chambers M, Hughes EG, Almiron DA, et al
    Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma.
    J Neurooncol. 2020 Jun 24. pii: 10.1007/s11060-020-03567.
    PubMed     Abstract available


  200. SHAH PP, White T, Khalafallah AM, Romo CG, et al
    A systematic review of tumor treating fields therapy for high-grade gliomas.
    J Neurooncol. 2020 Jun 23. pii: 10.1007/s11060-020-03563.
    PubMed     Abstract available


  201. MASSIMINO M, Sunyach MP, Barretta F, Gandola L, et al
    Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
    J Neurooncol. 2020 Jun 21. pii: 10.1007/s11060-020-03564.
    PubMed     Abstract available


  202. JACKSON C, Choi J, Khalafallah AM, Price C, et al
    A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.
    J Neurooncol. 2020 Jun 19. pii: 10.1007/s11060-020-03556.
    PubMed     Abstract available


  203. CROTTY EE, Leary SES, Geyer JR, Olson JM, et al
    Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
    J Neurooncol. 2020 Jun 16. pii: 10.1007/s11060-020-03558.
    PubMed     Abstract available


  204. GRABOWSKI MM, Sankey EW, Ryan KJ, Chongsathidkiet P, et al
    Immune suppression in gliomas.
    J Neurooncol. 2020 Jun 15. pii: 10.1007/s11060-020-03483.
    PubMed     Abstract available


  205. STEED TC, Treiber JM, Taha B, Engin HB, et al
    Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.
    J Neurooncol. 2020 Jun 15. pii: 10.1007/s11060-020-03550.
    PubMed     Abstract available


  206. WHITE RJ, Abel S, Horne ZD, Lee J, et al
    Melanoma brain metastases: is it time to eliminate radiotherapy?
    J Neurooncol. 2020 Jun 15. pii: 10.1007/s11060-020-03485.
    PubMed     Abstract available


  207. SHI W, Blumenthal DT, Oberheim Bush NA, Kebir S, et al
    Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
    J Neurooncol. 2020 Jun 13. pii: 10.1007/s11060-020-03540.
    PubMed     Abstract available


  208. LI Y, Lu D, Feng D, Cheng H, et al
    Management of incidental anterior skull base large and giant meningiomas in elderly patients.
    J Neurooncol. 2020 Jun 11. pii: 10.1007/s11060-020-03484.
    PubMed     Abstract available


  209. BARON RB, Lakomkin N, Schupper AJ, Nistal D, et al
    Postoperative outcomes following glioblastoma resection using a robot-assisted digital surgical exoscope: a case series.
    J Neurooncol. 2020 Jun 9. pii: 10.1007/s11060-020-03543.
    PubMed     Abstract available


  210. COHEN AL, Anker CJ, Johnson B, Burt LM, et al
    Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial.
    J Neurooncol. 2020 Jun 6. pii: 10.1007/s11060-020-03551.
    PubMed     Abstract available


  211. NELLAN A, Wright E, Campbell K, Davies KD, et al
    Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
    J Neurooncol. 2020 Jun 6. pii: 10.1007/s11060-020-03549.
    PubMed     Abstract available


  212. LIU B, Liu S, Wang Y, Lu D, et al
    Impact of neurosurgical enhanced recovery after surgery (ERAS) program on health-related quality of life in glioma patients: a secondary analysis of a randomized controlled trial.
    J Neurooncol. 2020 Jun 6. pii: 10.1007/s11060-020-03548.
    PubMed     Abstract available


  213. SUN Y, Bailey CP, Sadighi Z, Zaky W, et al
    Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities.
    J Neurooncol. 2020 Jun 5. pii: 10.1007/s11060-020-03546.
    PubMed     Abstract available


  214. PRADA F, Sheybani N, Franzini A, Moore D, et al
    Fluorescein-mediated sonodynamic therapy in a rat glioma model.
    J Neurooncol. 2020 Jun 4. pii: 10.1007/s11060-020-03536.
    PubMed     Abstract available


  215. KESSLER RA, Zimering J, Gilligan J, Rothrock R, et al
    Neurosurgical management of brain and spine tumors in the COVID-19 era: an institutional experience from the epicenter of the pandemic.
    J Neurooncol. 2020;148:211-219.
    PubMed     Abstract available


  216. GIORGIA S, Paola G, Antonio S
    Letter to editor: the burden of covid-19 in neuro-oncological patients.
    J Neurooncol. 2020;148:399-400.
    PubMed    


  217. SENEVIRATNE DS, Hadley AR, Peterson JL, Malouff TD, et al
    Assessment of unintended shifts during frame-based stereotactic radiosurgery using cone beam computed tomography image guidance.
    J Neurooncol. 2020;148:273-279.
    PubMed     Abstract available


  218. LIN YY, Wu HM, Yang HC, Chen CJ, et al
    Repeated gamma knife radiosurgery enables longer tumor control in cases of highly-recurrent intracranial ependymoma.
    J Neurooncol. 2020;148:363-372.
    PubMed     Abstract available


  219. BERTAUX M, Houillier C, Edeline V, Habert MO, et al
    Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study.
    J Neurooncol. 2020;148:343-352.
    PubMed     Abstract available


    May 2020
  220. JIN C, Zhao J, Zhang ZP, Wu M, et al
    Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma.
    J Neurooncol. 2020 May 29. pii: 10.1007/s11060-020-03544.
    PubMed     Abstract available


  221. LAMBA N, Mehanna E, Kearney RB, Catalano PJ, et al
    Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study.
    J Neurooncol. 2020 May 28. pii: 10.1007/s11060-020-03542.
    PubMed     Abstract available


  222. BHATTACHARYA D, Pomeroy SL, Pomeranz Krummel DA, Sengupta S, et al
    Epigenetics and survivorship in pediatric brain tumor patients.
    J Neurooncol. 2020 May 25. pii: 10.1007/s11060-020-03535.
    PubMed     Abstract available


  223. BERGMAN D, Modh A, Schultz L, Snyder J, et al
    Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma.
    J Neurooncol. 2020 May 22. pii: 10.1007/s11060-020-03526.
    PubMed     Abstract available


  224. WANG F, Gao Y, Lv Y, Wu Y, et al
    Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells.
    J Neurooncol. 2020 May 21. pii: 10.1007/s11060-020-03538.
    PubMed     Abstract available


  225. DONO A, Wang E, Lopez-Rivera V, Ramesh AV, et al
    Molecular characteristics and clinical features of multifocal glioblastoma.
    J Neurooncol. 2020 May 21. pii: 10.1007/s11060-020-03539.
    PubMed     Abstract available


  226. BARTEK J JR, Dhawan S, Thurin E, Alattar A, et al
    Short-term outcome following surgery for rare brain tumor entities in adults: a Swedish nation-wide registry-based study and comparison with SEER database.
    J Neurooncol. 2020 May 19. pii: 10.1007/s11060-020-03490.
    PubMed     Abstract available


  227. RIBEIRO M, Durand T, Roussel M, Feuvret L, et al
    Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
    J Neurooncol. 2020 May 15. pii: 10.1007/s11060-020-03524.
    PubMed     Abstract available


  228. HOFMANN S, Schmidt MA, Weissmann T, Eyupoglu I, et al
    Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with ("pseudo-randomized") treatment allocation by the health insurance provider.
    J Neurooncol. 2020 May 14. pii: 10.1007/s11060-020-03533.
    PubMed     Abstract available


  229. NI XR, Zhao YY, Cai HP, Yu ZH, et al
    Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models.
    J Neurooncol. 2020 May 13. pii: 10.1007/s11060-020-03527.
    PubMed     Abstract available


  230. WEE CW, Kim IH, Park CK, Kim N, et al
    Correction to: Chemoradiation in elderly patients with glioblastoma from the multiinstitutional GBMmolRPA cohort: is shortcourse radiotherapy enough or is it a matter of selection?
    J Neurooncol. 2020 May 12. pii: 10.1007/s11060-020-03532.
    PubMed     Abstract available


  231. DE BLANK P, Fouladi M, Huse JT
    Molecular markers and targeted therapy in pediatric low-grade glioma.
    J Neurooncol. 2020 May 12. pii: 10.1007/s11060-020-03529.
    PubMed     Abstract available


  232. DI L, Heath RN, Shah AH, Sanjurjo AD, et al
    Resection versus biopsy in the treatment of multifocal glioblastoma: a weighted survival analysis.
    J Neurooncol. 2020 May 11. pii: 10.1007/s11060-020-03508.
    PubMed     Abstract available


  233. LU VM, O'Connor KP, Shah AH, Eichberg DG, et al
    The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.
    J Neurooncol. 2020 May 8. pii: 10.1007/s11060-020-03528.
    PubMed     Abstract available


  234. NAGASAWA DT, Yang J, Romiyo P, Lagman C, et al
    Bioengineered recombinant vault nanoparticles coupled with NY-ESO-1 glioma-associated antigens induce maturation of native dendritic cells.
    J Neurooncol. 2020 May 7. pii: 10.1007/s11060-020-03472.
    PubMed     Abstract available


  235. NATSUME A, Aoki K, Ohka F, Maeda S, et al
    Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone.
    J Neurooncol. 2020 May 4. pii: 10.1007/s11060-020-03505.
    PubMed     Abstract available


  236. DIRVEN L, Luerding R, Beier D, Bumes E, et al
    Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
    J Neurooncol. 2020 May 4. pii: 10.1007/s11060-020-03502.
    PubMed     Abstract available


  237. ZREIK J, Moinuddin FM, Yolcu YU, Alvi MA, et al
    Improved 3-year survival rates for glioblastoma multiforme are associated with trends in treatment: analysis of the national cancer database from 2004 to 2013.
    J Neurooncol. 2020 May 3. pii: 10.1007/s11060-020-03469.
    PubMed     Abstract available


  238. SHEEHAN K, Sheehan D, Sulaiman M, Padilla F, et al
    Investigation of the tumoricidal effects of sonodynamic therapy in malignant glioblastoma brain tumors.
    J Neurooncol. 2020 May 2. pii: 10.1007/s11060-020-03504.
    PubMed     Abstract available


  239. WEE CW, Kim IH, Park CK, Kim N, et al
    Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort: is short-course radiotherapy enough or is it a matter of selection?
    J Neurooncol. 2020 May 2. pii: 10.1007/s11060-020-03468.
    PubMed     Abstract available


  240. RAMAKRISHNA R, Zadeh G, Sheehan JP, Aghi MK, et al
    Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.
    J Neurooncol. 2020;147:525-529.
    PubMed     Abstract available


  241. FINOCCHIARO G
    Milan 2020: COVID-19, neuro-oncology and much more.
    J Neurooncol. 2020;148:201-202.
    PubMed    


  242. PERIN A, Servadei F, DiMeco F
    May we deliver neuro-oncology in difficult times (e.g. COVID-19)?
    J Neurooncol. 2020;148:203-205.
    PubMed    


  243. HU YJ, Zhang JM, Chen ZP
    Experiences of practicing surgical neuro-oncology during the COVID-19 pandemic.
    J Neurooncol. 2020;148:199-200.
    PubMed    


  244. SULEIMAN M, Bunevicius A, Sheehan J
    Stereotactic radiosurgery for management of recurring Choroid Plexus Metastases from Non-Small Cell Lung Carcinoma.
    J Neurooncol. 2020;148:207-209.
    PubMed    


  245. MICHAIEL G, Strother D, Gottardo N, Bartels U, et al
    Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature.
    J Neurooncol. 2020;147:721-730.
    PubMed     Abstract available


  246. WEIDMAN DR, Palasamudram S, Zak M, Whitney R, et al
    The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    J Neurooncol. 2020;147:731-736.
    PubMed     Abstract available


  247. YEUNG JT, Vesely MD, Miyagishima DF
    In silico analysis of the immunological landscape of pituitary adenomas.
    J Neurooncol. 2020;147:595-598.
    PubMed     Abstract available


  248. KANNO H, Yoshizumi T, Shinonaga M, Kubo A, et al
    Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.
    J Neurooncol. 2020;148:29-38.
    PubMed     Abstract available


  249. MORSHED RA, Reihl SJ, Molinaro AM, Kakaizada S, et al
    The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment.
    J Neurooncol. 2020;148:131-139.
    PubMed     Abstract available


  250. CHEN TW, Jan IS, Chang DY, Lin CH, et al
    Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.
    J Neurooncol. 2020;148:165-172.
    PubMed     Abstract available


  251. NATHAN NH, Connor M, Sizdahkhani S, Ding L, et al
    Increased 30-day readmission rate after craniotomy for tumor resection at safety net hospitals in small metropolitan areas.
    J Neurooncol. 2020;148:141-154.
    PubMed     Abstract available


  252. THOMAS C, Metrock K, Kordes U, Hasselblatt M, et al
    Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors.
    J Neurooncol. 2020;148:39-45.
    PubMed     Abstract available


  253. MAIR MJ, Wohrer A, Furtner J, Simonovska A, et al
    Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma.
    J Neurooncol. 2020;148:187-198.
    PubMed     Abstract available


  254. WANG H, Wang R, Hu T, Wang Z, et al
    Nonfunctioning pituitary adenomas in pediatric and adolescent patients: a clinical analysis of a series of 14 patients.
    J Neurooncol. 2020;148:179-186.
    PubMed     Abstract available


    April 2020
  255. FANG S, Li Y, Wang Y, Zhang Z, et al
    Awake craniotomy for gliomas involving motor-related areas: classification and function recovery.
    J Neurooncol. 2020 Apr 29. pii: 10.1007/s11060-020-03520.
    PubMed     Abstract available


  256. MANDRELL BN, LaRosa K, Hancock D, Caples M, et al
    Predictors of narcolepsy and hypersomnia due to medical disorder in pediatric craniopharyngioma.
    J Neurooncol. 2020 Apr 28. pii: 10.1007/s11060-020-03519.
    PubMed     Abstract available


  257. MAGGIO D, Ho WS, Breese R, Walbridge S, et al
    Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma.
    J Neurooncol. 2020 Apr 27. pii: 10.1007/s11060-020-03517.
    PubMed     Abstract available


  258. HUO M, Laperriere N, van Prooijen M, Shultz D, et al
    Efficacy of stereotactic radiosurgery for radiation-induced meningiomas.
    J Neurooncol. 2020 Apr 27. pii: 10.1007/s11060-020-03515.
    PubMed     Abstract available


  259. SCHWARTZ C, Rautalin I, Niemela M, Korja M, et al
    Symptomatic peritumoral edema is associated with surgical outcome: a consecutive series of 72 supratentorial meningioma patients >/= 80 years of age.
    J Neurooncol. 2020 Apr 22. pii: 10.1007/s11060-020-03501.
    PubMed     Abstract available


  260. LEBOW ES, Hwang WL, Zieminski S, Wang Y, et al
    Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases.
    J Neurooncol. 2020 Apr 19. pii: 10.1007/s11060-020-03491.
    PubMed     Abstract available


  261. ZIGIOTTO L, Annicchiarico L, Corsini F, Vitali L, et al
    Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery.
    J Neurooncol. 2020 Apr 17. pii: 10.1007/s11060-020-03494.
    PubMed     Abstract available


  262. TEYATEETI A, Brown PD, Mahajan A, Laack NN, et al
    Brain metastases resection cavity radio-surgery based on T2-weighted MRI: technique assessment.
    J Neurooncol. 2020 Apr 17. pii: 10.1007/s11060-020-03492.
    PubMed     Abstract available


  263. VOTH BL, Pelargos PE, Barnette NE, Bhatt NS, et al
    Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma.
    J Neurooncol. 2020 Apr 9. pii: 10.1007/s11060-020-03479.
    PubMed     Abstract available


  264. GOGOS AJ, Young JS, Morshed RA, Hervey-Jumper SL, et al
    Awake glioma surgery: technical evolution and nuances.
    J Neurooncol. 2020 Apr 8. pii: 10.1007/s11060-020-03482.
    PubMed     Abstract available


  265. ZHANG L, Hu Y, Chen W, Tian Y, et al
    Pre-stereotactic radiosurgery neutrophil-to-lymphocyte ratio is a predictor of the prognosis for brain metastases.
    J Neurooncol. 2020 Apr 6. pii: 10.1007/s11060-020-03477.
    PubMed     Abstract available


  266. MEDIKONDA R, Dunn G, Rahman M, Fecci P, et al
    A review of glioblastoma immunotherapy.
    J Neurooncol. 2020 Apr 6. pii: 10.1007/s11060-020-03448.
    PubMed     Abstract available


  267. MARX S, Wilken F, Wagner I, Marx M, et al
    GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma.
    J Neurooncol. 2020 Apr 3. pii: 10.1007/s11060-020-03470.
    PubMed     Abstract available


  268. HONIKL LS, Lammer F, Gempt J, Meyer B, et al
    High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients.
    J Neurooncol. 2020 Apr 2. pii: 10.1007/s11060-020-03467.
    PubMed     Abstract available


  269. EL SHAFIE RA, Celik A, Weber D, Schmitt D, et al
    A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
    J Neurooncol. 2020 Apr 1. pii: 10.1007/s11060-020-03447.
    PubMed     Abstract available


  270. MANNING P, Daghighi S, Rajaratnam MK, Parthiban S, et al
    Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
    J Neurooncol. 2020 Apr 1. pii: 10.1007/s11060-020-03475.
    PubMed     Abstract available


  271. CHO N, Wang C, Raymond C, Kaprealian T, et al
    Diffusion MRI changes in the anterior subventricular zone following chemoradiation in glioblastoma with posterior ventricular involvement.
    J Neurooncol. 2020 Apr 1. pii: 10.1007/s11060-020-03460.
    PubMed     Abstract available


  272. SHIN DW, Kim JH, Kim YH, Cho YH, et al
    Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.
    J Neurooncol. 2020;147:339-349.
    PubMed     Abstract available


  273. GUO Y, He X, Zhang M, Qu Y, et al
    Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
    J Neurooncol. 2020;147:327-337.
    PubMed     Abstract available


  274. WILLEKE VM, Anderson MP, Mahadevan A, Rojas R, et al
    Epstein Barr virus associated smooth muscle tumors in the central nervous system: a case report and systematic review of the literature.
    J Neurooncol. 2020;147:247-260.
    PubMed     Abstract available


  275. PATEL MP, Kirkpatrick JP, Johnson MO, Healy P, et al
    Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.
    J Neurooncol. 2020;147:477-483.
    PubMed     Abstract available


  276. PALMER JD, Bhamidipati D, Shukla G, Epperla N, et al
    Outcomes after stereotactic radiosurgery for CNS lymphoma.
    J Neurooncol. 2020;147:465-476.
    PubMed     Abstract available


  277. D'AMICO RS, Khatri D, Reichman N, Patel NV, et al
    Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.
    J Neurooncol. 2020;147:261-278.
    PubMed     Abstract available


  278. GUPTA T, Maitre M, Gupta P, Krishnatry R, et al
    Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
    J Neurooncol. 2020;147:405-415.
    PubMed     Abstract available


    March 2020
  279. LU VM, Shah AH, Eichberg DG, Quinones-Hinojosa A, et al
    Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database.
    J Neurooncol. 2020 Mar 31. pii: 10.1007/s11060-020-03480.
    PubMed     Abstract available


  280. HERTLER C, Eisele G, Gramatzki D, Seystahl K, et al
    End-of-life care for glioma patients; the caregivers' perspective.
    J Neurooncol. 2020 Mar 30. pii: 10.1007/s11060-020-03471.
    PubMed     Abstract available


  281. VERGARA GA, Eugenio GC, Malheiros SMF, Victor EDS, et al
    RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping.
    J Neurooncol. 2020 Mar 28. pii: 10.1007/s11060-020-03473.
    PubMed     Abstract available


  282. EICHBERG DG, Di L, Morell AA, Shah AH, et al
    Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis.
    J Neurooncol. 2020 Mar 27. pii: 10.1007/s11060-020-03474.
    PubMed     Abstract available


  283. STESSIN AM, Clausi MG, Zhao Z, Lin H, et al
    Repolarized macrophages, induced by intermediate stereotactic dose radiotherapy and immune checkpoint blockade, contribute to long-term survival in glioma-bearing mice.
    J Neurooncol. 2020 Mar 25. pii: 10.1007/s11060-020-03459.
    PubMed     Abstract available


  284. SONG A, Bar-Ad V, Martinez N, Glass J, et al
    Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.
    J Neurooncol. 2020 Mar 23. pii: 10.1007/s11060-020-03466.
    PubMed     Abstract available


  285. BHAMBHVANI HP, Rodrigues AJ, Medress ZA, Hayden Gephart M, et al
    Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study.
    J Neurooncol. 2020 Mar 19. pii: 10.1007/s11060-020-03455.
    PubMed     Abstract available


  286. GALLITTO M, Cheng He R, Inocencio JF, Wang H, et al
    Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1.
    J Neurooncol. 2020 Mar 19. pii: 10.1007/s11060-020-03461.
    PubMed     Abstract available


  287. KWOK D, Okada H
    T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment.
    J Neurooncol. 2020 Mar 17. pii: 10.1007/s11060-020-03450.
    PubMed     Abstract available


  288. NUNNA RS, Khalid S, Ryoo JS, Mehta AI, et al
    Adult primary high-grade spinal glioma: a nationwide analysis of current trends in treatment and outcomes.
    J Neurooncol. 2020 Mar 17. pii: 10.1007/s11060-020-03458.
    PubMed     Abstract available


  289. MOREIRA DC, Venkataraman S, Subramanian A, Desisto J, et al
    Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine.
    J Neurooncol. 2020 Mar 16. pii: 10.1007/s11060-020-03457.
    PubMed     Abstract available


  290. BOELE FW, Meads D, Jansen F, Verdonck-de Leeuw IM, et al
    Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms.
    J Neurooncol. 2020 Mar 14. pii: 10.1007/s11060-020-03454.
    PubMed     Abstract available


  291. NIU X, Wang T, Zhou X, Yang Y, et al
    Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years.
    J Neurooncol. 2020 Mar 10. pii: 10.1007/s11060-020-03430.
    PubMed     Abstract available


  292. MARENCO-HILLEMBRAND L, Wijesekera O, Suarez-Meade P, Mampre D, et al
    Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis.
    J Neurooncol. 2020 Mar 9. pii: 10.1007/s11060-020-03451.
    PubMed     Abstract available


  293. ZUMEL-MARNE A, Kundi M, Castano-Vinyals G, Alguacil J, et al
    Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study.
    J Neurooncol. 2020 Mar 3. pii: 10.1007/s11060-020-03437.
    PubMed     Abstract available


  294. AMBADY P, Fu R, Szidonya L, Peereboom DM, et al
    Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.
    J Neurooncol. 2020;147:171-176.
    PubMed     Abstract available


  295. BETTE S, Gradtke CV, Cammardella JH, Albertshauser J, et al
    Perioperative neurocognitive functions in patients with neuroepithelial intracranial tumors.
    J Neurooncol. 2020;147:77-89.
    PubMed     Abstract available


  296. FERREIRA MSV, Sorensen MD, Pusch S, Beier D, et al
    Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
    J Neurooncol. 2020;147:1-14.
    PubMed     Abstract available


    February 2020
  297. KELLY WJ, Gilbert MR
    Glucocorticoids and immune checkpoint inhibitors in glioblastoma.
    J Neurooncol. 2020 Feb 27. pii: 10.1007/s11060-020-03439.
    PubMed     Abstract available


  298. GIUSEPPE M, Luca C, Barbara N, Randa EG, et al
    Neurological outcome and memory performance in patients with 10 or more brain metastases treated with frameless linear accelerator (LINAC)-based stereotactic radiosurgery.
    J Neurooncol. 2020 Feb 25. pii: 10.1007/s11060-020-03442.
    PubMed     Abstract available


  299. VALLEJO FA, Shah SS, de Cordoba N, Walters WM, et al
    The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.
    J Neurooncol. 2020 Feb 24. pii: 10.1007/s11060-020-03431.
    PubMed     Abstract available


  300. ROWE L, Vera E, Acquaye A, Crandon S, et al
    The prevalence of altered body image in patients with primary brain tumors: an understudied population.
    J Neurooncol. 2020 Feb 24. pii: 10.1007/s11060-020-03433.
    PubMed     Abstract available


  301. HUA L, Wang D, Zhu H, Deng J, et al
    Long-term outcomes of multimodality management for parasagittal meningiomas.
    J Neurooncol. 2020 Feb 22. pii: 10.1007/s11060-020-03440.
    PubMed     Abstract available


  302. VERBRUGGEN LC, Hudson MM, Bowers DC, Ronckers CM, et al
    Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors.
    J Neurooncol. 2020 Feb 22. pii: 10.1007/s11060-020-03436.
    PubMed     Abstract available


  303. RUTENBERG MS, Rotondo RL, Rao D, Holtzman AL, et al
    Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study.
    J Neurooncol. 2020 Feb 21. pii: 10.1007/s11060-020-03432.
    PubMed     Abstract available


  304. SCHROEDER T, Bittrich P, Kuhne JF, Noebel C, et al
    Mapping distribution of brain metastases: does the primary tumor matter?
    J Neurooncol. 2020 Feb 17. pii: 10.1007/s11060-020-03419.
    PubMed     Abstract available


  305. RAJ R, Seppa K, Luostarinen T, Malila N, et al
    Disparities in glioblastoma survival by case volume: a nationwide observational study.
    J Neurooncol. 2020 Feb 14. pii: 10.1007/s11060-020-03428.
    PubMed     Abstract available


  306. NORDAN T, Thomas AM, Ginsburg ES, Wen PY, et al
    Fertility preservation outcomes in women with gliomas: a retrospective case-control study.
    J Neurooncol. 2020 Feb 14. pii: 10.1007/s11060-020-03429.
    PubMed     Abstract available


  307. DAHLIN AM, Wibom C, Andersson U, Bybjerg-Grauholm J, et al
    A genome-wide association study on medulloblastoma.
    J Neurooncol. 2020 Feb 13. pii: 10.1007/s11060-020-03424.
    PubMed     Abstract available


  308. LEHRER EJ, McGee HM, Sheehan JP, Trifiletti DM, et al
    Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases.
    J Neurooncol. 2020 Feb 12. pii: 10.1007/s11060-020-03427.
    PubMed     Abstract available


  309. MARTIN-MCGILL KJ, Marson AG, Tudur Smith C, Young B, et al
    Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study.
    J Neurooncol. 2020 Feb 8. pii: 10.1007/s11060-020-03417.
    PubMed     Abstract available


  310. MALBARI F, Staggers KA, Minard CG, Weiner HL, et al
    Provider views on perioperative steroid use for patients with newly diagnosed pediatric brain tumors.
    J Neurooncol. 2020 Feb 5. pii: 10.1007/s11060-020-03416.
    PubMed     Abstract available


  311. ITO D, Aoyagi K, Nagano O, Serizawa T, et al
    Comparison of two-stage Gamma Knife radiosurgery outcomes for large brain metastases among primary cancers.
    J Neurooncol. 2020 Feb 5. pii: 10.1007/s11060-020-03421.
    PubMed     Abstract available


  312. TINKLE CL, Campbell K, Han Y, Li Y, et al
    Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
    J Neurooncol. 2020 Feb 3. pii: 10.1007/s11060-020-03415.
    PubMed     Abstract available


  313. GAO Y, Li L, Zheng H, Zhou C, et al
    KIF3C is associated with favorable prognosis in glioma patients and may be regulated by PI3K/AKT/mTOR pathway.
    J Neurooncol. 2020;146:513-521.
    PubMed     Abstract available


  314. YAMAKI T, Shibahra I, Matsuda KI, Kanemura Y, et al
    Relationships between recurrence patterns and subventricular zone involvement or CD133 expression in glioblastoma.
    J Neurooncol. 2020;146:489-499.
    PubMed     Abstract available


  315. MOIYADI A, Shetty P, Sridhar E, Gota V, et al
    Objective assessment of intraoperative tumor fluorescence reveals biological heterogeneity within glioblastomas: a biometric study.
    J Neurooncol. 2020;146:477-488.
    PubMed     Abstract available


  316. OHBA S, Hirose Y
    L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells.
    J Neurooncol. 2020;146:469-475.
    PubMed     Abstract available


  317. PAN SY, Chen JP, Cheng WY, Lee HT, et al
    The role of tailored intraoperative neurophysiological monitoring in glioma surgery: a single institute experience.
    J Neurooncol. 2020;146:459-467.
    PubMed     Abstract available


  318. HATA N, Mizoguchi M, Kuga D, Hatae R, et al
    First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide.
    J Neurooncol. 2020;146:451-458.
    PubMed     Abstract available


  319. HUANG CY, Lee CC, Yang HC, Lin CJ, et al
    Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.
    J Neurooncol. 2020;146:439-449.
    PubMed     Abstract available


  320. TIBURCIO PDB, Gillespie DL, Jensen RL, Huang LE, et al
    Extracellular glutamate and IDH1(R132H) inhibitor promote glioma growth by boosting redox potential.
    J Neurooncol. 2020;146:427-437.
    PubMed     Abstract available


  321. HSU SPC, Chen YC, Chiang HC, Huang YC, et al
    Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors.
    J Neurooncol. 2020;146:417-426.
    PubMed     Abstract available


  322. CHEN SC, Lin CF, Liao CH, Quilis-Quesada V, et al
    The pretemporal trans-cavernous trans-Meckel's trans-tentorial trans-petrosal approach: a combo skill in treating skull base meningiomas.
    J Neurooncol. 2020;146:407-416.
    PubMed     Abstract available


  323. KIM CY, Paek SH, Nam DH, Chang JH, et al
    Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
    J Neurooncol. 2020;146:399-406.
    PubMed     Abstract available


    January 2020
  324. LI Z, Li G, Liu Z, Pan Y, et al
    Transcortical approach for insular gliomas: a series of 253 patients.
    J Neurooncol. 2020 Jan 31. pii: 10.1007/s11060-020-03390.
    PubMed     Abstract available


  325. OLAFSON LR, Gunawardena M, Nixdorf S, McDonald KL, et al
    The role of TP53 gain-of-function mutation in multifocal glioblastoma.
    J Neurooncol. 2020 Jan 30. pii: 10.1007/s11060-019-03318.
    PubMed     Abstract available


  326. GUERDOUX-NINOT E, Bauchet L, Legninda Sop FY, Gourgou S, et al
    Prospective memory and brain metastases: a relevant target for rehabilitation in post-operative patients?
    J Neurooncol. 2020 Jan 30. pii: 10.1007/s11060-020-03414.
    PubMed     Abstract available


  327. LOK E, San P, Liang O, White V, et al
    Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastoma.
    J Neurooncol. 2020 Jan 27. pii: 10.1007/s11060-020-03406.
    PubMed     Abstract available


  328. YAMAMOTO M, Serizawa T, Nagano O, Aoyagi K, et al
    Three-institution study on applicability of initial brain metastasis velocity for breast cancer brain metastasis patients undergoing stereotactic radiosurgery.
    J Neurooncol. 2020 Jan 27. pii: 10.1007/s11060-020-03412.
    PubMed     Abstract available


  329. SKJULSVIK AJ, Bo HK, Jakola AS, Berntsen EM, et al
    Is the anatomical distribution of low-grade gliomas linked to regions of gliogenesis?
    J Neurooncol. 2020 Jan 25. pii: 10.1007/s11060-020-03409.
    PubMed     Abstract available


  330. PATEL KS, Kejriwal S, Sun MM, Thammachantha S, et al
    Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.
    J Neurooncol. 2020 Jan 24. pii: 10.1007/s11060-020-03401.
    PubMed     Abstract available


  331. OUGHOURLIAN TC, Yao J, Schlossman J, Raymond C, et al
    Rate of change in maximum (18)F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas.
    J Neurooncol. 2020 Jan 24. pii: 10.1007/s11060-020-03407.
    PubMed     Abstract available


  332. SCHEI S, Solheim O, Jakola AS, Sagberg LM, et al
    Perioperative fatigue in patients with diffuse glioma.
    J Neurooncol. 2020 Jan 23. pii: 10.1007/s11060-020-03403.
    PubMed     Abstract available


  333. CARVALHO B, Lopes RG, Linhares P, Costa A, et al
    Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients.
    J Neurooncol. 2020 Jan 23. pii: 10.1007/s11060-020-03404.
    PubMed     Abstract available


  334. CHAMPEAUX C, Weller J
    Implantation of carmustine wafers (Gliadel((R))) for high-grade glioma treatment. A 9-year nationwide retrospective study.
    J Neurooncol. 2020 Jan 23. pii: 10.1007/s11060-020-03410.
    PubMed     Abstract available


  335. ZHONG J, Waldman AD, Kandula S, Eaton BR, et al
    Outcomes of whole-brain radiation with simultaneous in-field boost (SIB) for the treatment of brain metastases.
    J Neurooncol. 2020 Jan 22. pii: 10.1007/s11060-020-03405.
    PubMed     Abstract available


  336. PARR E, Sleightholm RL, Baine MJ, Shonka NA, et al
    Efficacy of sequential radiation and chemotherapy in treating glioblastoma with poor performance status.
    J Neurooncol. 2020 Jan 20. pii: 10.1007/s11060-020-03402.
    PubMed     Abstract available


  337. BELGERS V, Numan T, Kulik SD, Hillebrand A, et al
    Postoperative oscillatory brain activity as an add-on prognostic marker in diffuse glioma.
    J Neurooncol. 2020 Jan 17. pii: 10.1007/s11060-019-03386.
    PubMed     Abstract available


  338. FARINA NUNEZ MT, Franco P, Cipriani D, Neidert N, et al
    Resection of recurrent glioblastoma multiforme in elderly patients: a pseudo-randomized analysis revealed clinical benefit.
    J Neurooncol. 2020 Jan 13. pii: 10.1007/s11060-020-03393.
    PubMed     Abstract available


  339. NAKAZAKI K, Yomo S, Kondoh T, Serizawa T, et al
    Salvage gamma knife radiosurgery for active brain metastases from small-cell lung cancer after whole-brain radiation therapy: a retrospective multi-institutional study (JLGK1701).
    J Neurooncol. 2020 Jan 13. pii: 10.1007/s11060-020-03397.
    PubMed     Abstract available


  340. JAKOLA AS, Bouget D, Reinertsen I, Skjulsvik AJ, et al
    Spatial distribution of malignant transformation in patients with low-grade glioma.
    J Neurooncol. 2020 Jan 9. pii: 10.1007/s11060-020-03391.
    PubMed     Abstract available


  341. DE MOOIJ T, Peterson TE, Evans J, McCutcheon B, et al
    Short non-coding RNA sequencing of glioblastoma extracellular vesicles.
    J Neurooncol. 2020 Jan 7. pii: 10.1007/s11060-019-03384.
    PubMed     Abstract available


  342. GARIMALL S, Shanker M, Johns E, Watkins T, et al
    Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
    J Neurooncol. 2020 Jan 6. pii: 10.1007/s11060-019-03383.
    PubMed     Abstract available


  343. YANG Y, Yang Y, Wu X, Pan Y, et al
    Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
    J Neurooncol. 2020 Jan 4. pii: 10.1007/s11060-019-03387.
    PubMed     Abstract available


  344. KERIC N, Kalasauskas D, Freyschlag CF, Gempt J, et al
    Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    J Neurooncol. 2020 Jan 3. pii: 10.1007/s11060-019-03382.
    PubMed     Abstract available


  345. LECOMPTE MC, Hughes RT, Farris M, Masters A, et al
    Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery.
    J Neurooncol. 2020 Jan 1. pii: 10.1007/s11060-019-03368.
    PubMed     Abstract available


  346. KALRA B, Kannan S, Gupta T
    Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis.
    J Neurooncol. 2020 Jan 1. pii: 10.1007/s11060-019-03375.
    PubMed     Abstract available


  347. PEETERS MCM, Dirven L, Koekkoek JAF, Gortmaker EG, et al
    Prediagnostic symptoms and signs of adult glioma: the patients' view.
    J Neurooncol. 2020 Jan 1. pii: 10.1007/s11060-019-03373.
    PubMed     Abstract available


  348. YOUNGERMAN BE, Joiner EF, Wang X, Yang J, et al
    Patterns of seizure prophylaxis after oncologic neurosurgery.
    J Neurooncol. 2020;146:171-180.
    PubMed     Abstract available


  349. NISHIMOTO M, Ohara K, Kamamoto D, Tamura R, et al
    Tumor immune microenvironment is associated with the growth of intracranial germinomas.
    J Neurooncol. 2020;146:139-146.
    PubMed     Abstract available


  350. LIN AJ, Kane LT, Molitoris JK, Smith DR, et al
    A multi-institutional analysis of clinical outcomes and patterns of care of 1p/19q codeleted oligodendrogliomas treated with adjuvant or salvage radiation therapy.
    J Neurooncol. 2020;146:121-130.
    PubMed     Abstract available


  351. LUTHER EM, McCarthy D, Berry KM, Rajulapati N, et al
    Hospital teaching status associated with reduced inpatient mortality and perioperative complications in surgical neuro-oncology.
    J Neurooncol. 2020;146:389-396.
    PubMed     Abstract available


  352. NG S, Fomekong F, Delabar V, Jacquesson T, et al
    Current status and treatment modalities in metastases to the pituitary: a systematic review.
    J Neurooncol. 2020;146:219-227.
    PubMed     Abstract available


  353. AHSAN SA, Chendeb K, Briggs RG, Fletcher LR, et al
    Beyond eloquence and onto centrality: a new paradigm in planning supratentorial neurosurgery.
    J Neurooncol. 2020;146:229-238.
    PubMed     Abstract available


  354. UMEMURA Y, Wang D, Peck KK, Flynn J, et al
    DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy.
    J Neurooncol. 2020;146:339-346.
    PubMed     Abstract available


    December 2019
  355. ARMOCIDA D, Pesce A, Frati A, Santoro A, et al
    EGFR amplification is a real independent prognostic impact factor between young adults and adults over 45yo with wild-type glioblastoma?
    J Neurooncol. 2019 Dec 30. pii: 10.1007/s11060-019-03364.
    PubMed     Abstract available


  356. CARSTAM L, Ryden I, Gulati S, Rydenhag B, et al
    Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study.
    J Neurooncol. 2019 Dec 27. pii: 10.1007/s11060-019-03378.
    PubMed     Abstract available


  357. BIKHEZAR F, de Kruijff RM, van der Meer AJGM, Torrelo Villa G, et al
    Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
    J Neurooncol. 2019 Dec 24. pii: 10.1007/s11060-019-03365.
    PubMed     Abstract available


  358. GILANI A, Donson A, Davies KD, Whiteway SL, et al
    Targetable molecular alterations in congenital glioblastoma.
    J Neurooncol. 2019 Dec 24. pii: 10.1007/s11060-019-03377.
    PubMed     Abstract available


  359. KEREZOUDIS P, Goyal A, Lu VM, Alvi MA, et al
    The role of radiation and chemotherapy in adult patients with high-grade brainstem gliomas: results from the National Cancer Database.
    J Neurooncol. 2019 Dec 24. pii: 10.1007/s11060-019-03374.
    PubMed     Abstract available


  360. MATSUI Y, Maruyama T, Nitta M, Saito T, et al
    Prediction of lower-grade glioma molecular subtypes using deep learning.
    J Neurooncol. 2019 Dec 21. pii: 10.1007/s11060-019-03376.
    PubMed     Abstract available


  361. YOSHIDA A, Motomura K, Natsume A, Chalise L, et al
    Preoperative predictive factors affecting return to work in patients with gliomas undergoing awake brain mapping.
    J Neurooncol. 2019 Dec 18. pii: 10.1007/s11060-019-03371.
    PubMed     Abstract available


  362. SONG LR, Weng JC, Huo XL, Wang L, et al
    Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
    J Neurooncol. 2019 Dec 18. pii: 10.1007/s11060-019-03372.
    PubMed     Abstract available


  363. MARTINS F, Schiappacasse L, Levivier M, Tuleasca C, et al
    The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
    J Neurooncol. 2019 Dec 14. pii: 10.1007/s11060-019-03363.
    PubMed     Abstract available


  364. SCHAFF LR, Yan D, Thyparambil S, Tian Y, et al
    Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival.
    J Neurooncol. 2019 Dec 10. pii: 10.1007/s11060-019-03358.
    PubMed     Abstract available


  365. VAN KESSEL E, Snijders TJ, Baumfalk AE, Ruis C, et al
    Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study.
    J Neurooncol. 2019 Dec 4. pii: 10.1007/s11060-019-03341.
    PubMed     Abstract available


  366. RULSEH AM, Vymazal J
    Whole brain apparent diffusion coefficient measurements correlate with survival in glioblastoma patients.
    J Neurooncol. 2019 Dec 3. pii: 10.1007/s11060-019-03357.
    PubMed     Abstract available


    November 2019
  367. HEITZER AM, Villagran AM, Raghubar K, Brown AL, et al
    Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor.
    J Neurooncol. 2019 Nov 28. pii: 10.1007/s11060-019-03356.
    PubMed     Abstract available


  368. BERBERICH A, Schmitt LM, Pusch S, Hielscher T, et al
    cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma.
    J Neurooncol. 2019 Nov 28. pii: 10.1007/s11060-019-03348.
    PubMed     Abstract available


  369. VAN DEN BENT M, Azaro A, De Vos F, Sepulveda J, et al
    A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.
    J Neurooncol. 2019 Nov 27. pii: 10.1007/s11060-019-03337.
    PubMed     Abstract available


  370. KARUNAMUNI R, Tringale KR, Burkeen J, Tibbs MD, et al
    Multi-domain neurocognitive classification of primary brain tumor patients prior to radiotherapy on a prospective clinical trial.
    J Neurooncol. 2019 Nov 23. pii: 10.1007/s11060-019-03353.
    PubMed     Abstract available


  371. KARKI K, Li X, Jin UH, Mohankumar K, et al
    Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.
    J Neurooncol. 2019 Nov 21. pii: 10.1007/s11060-019-03349.
    PubMed     Abstract available


  372. MOONEY MA, Bi WL, Cantalino JM, Wu KC, et al
    Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
    J Neurooncol. 2019 Nov 19. pii: 10.1007/s11060-019-03342.
    PubMed     Abstract available


  373. GUYOT A, Duchesne M, Robert S, Lia AS, et al
    Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.
    J Neurooncol. 2019 Nov 15. pii: 10.1007/s11060-019-03333.
    PubMed     Abstract available


  374. NICHELLI L, Dormont D, Sanson M, Di Stefano AL, et al
    EGFR gene amplification in monocentric and multicentric glioblastoma.
    J Neurooncol. 2019 Nov 15. pii: 10.1007/s11060-019-03324.
    PubMed    


  375. ALCAIDE-LEON P, Luks TL, Lafontaine M, Lupo JM, et al
    Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy.
    J Neurooncol. 2019 Nov 14. pii: 10.1007/s11060-019-03336.
    PubMed     Abstract available


  376. IZZUDDEEN Y, Gupta S, Haresh KP, Sharma D, et al
    Hypofractionated radiotherapy with temozolomide in diffuse intrinsic pontine gliomas: a randomized controlled trial.
    J Neurooncol. 2019 Nov 14. pii: 10.1007/s11060-019-03340.
    PubMed     Abstract available


  377. BAUMANN C, Tichy J, Schaefer JH, Steinbach JP, et al
    Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation.
    J Neurooncol. 2019 Nov 11. pii: 10.1007/s11060-019-03335.
    PubMed     Abstract available


  378. BICZOK A, Jungk C, Egensperger R, von Deimling A, et al
    Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.
    J Neurooncol. 2019 Nov 11. pii: 10.1007/s11060-019-03312.
    PubMed     Abstract available


  379. CHOI SW, Cho KR, Choi JW, Kong DS, et al
    Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery.
    J Neurooncol. 2019 Nov 8. pii: 10.1007/s11060-019-03328.
    PubMed     Abstract available


  380. PINSON H, Hallaert G, Van der Meulen J, Dedeurwaerdere F, et al
    Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.
    J Neurooncol. 2019 Nov 7. pii: 10.1007/s11060-019-03334.
    PubMed     Abstract available


  381. JARDIM A, Scott J, Drew Z, Foote MC, et al
    Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases.
    J Neurooncol. 2019 Nov 5. pii: 10.1007/s11060-019-03330.
    PubMed     Abstract available


  382. RUDA R, Pellerino A, Pace A, Carapella CM, et al
    Correction to: Efficacy of initial temozolomide for highrisk low grade gliomas in a phase II AINO (Italian Association for NeuroOncology) study: a posthoc analysis within molecular subgroups of WHO 2016.
    J Neurooncol. 2019 Nov 5. pii: 10.1007/s11060-019-03331.
    PubMed     Abstract available


  383. WICK W, Krendyukov A, Junge K, Hoger T, et al
    Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients.
    J Neurooncol. 2019 Nov 2. pii: 10.1007/s11060-019-03320.
    PubMed     Abstract available


    October 2019
  384. TRISOLINI E, Wardighi DE, Giry M, Bernardi P, et al
    Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas.
    J Neurooncol. 2019 Oct 31. pii: 10.1007/s11060-019-03306.
    PubMed     Abstract available


  385. KOYASU S, Shimizu Y, Morinibu A, Saga T, et al
    Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.
    J Neurooncol. 2019 Oct 30. pii: 10.1007/s11060-019-03322.
    PubMed     Abstract available


  386. IORIO-MORIN C, Mercure-Cyr R, Figueiredo G, Touchette CJ, et al
    Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases.
    J Neurooncol. 2019 Oct 30. pii: 10.1007/s11060-019-03323.
    PubMed     Abstract available


  387. CIFARELLI CP, Brehmer S, Vargo JA, Hack JD, et al
    Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study.
    J Neurooncol. 2019 Oct 25. pii: 10.1007/s11060-019-03309.
    PubMed     Abstract available


  388. YOUSSEF M, Ludmir EB, Mandel JJ, Patel AJ, et al
    Treatment strategies for glioblastoma in older patients: age is just a number.
    J Neurooncol. 2019 Oct 23. pii: 10.1007/s11060-019-03304.
    PubMed     Abstract available


  389. CAJIGAS I, Mahavadi AK, Shah AH, Borowy V, et al
    Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center.
    J Neurooncol. 2019 Oct 22. pii: 10.1007/s11060-019-03317.
    PubMed     Abstract available


  390. CAREY SS, Sadighi Z, Wu S, Chiang J, et al
    Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis.
    J Neurooncol. 2019 Oct 22. pii: 10.1007/s11060-019-03319.
    PubMed     Abstract available


  391. LE RHUN E, Devos P, Bourg V, Darlix A, et al
    Complementary and alternative medicine use in glioma patients in France.
    J Neurooncol. 2019 Oct 21. pii: 10.1007/s11060-019-03315.
    PubMed     Abstract available


  392. VERA S, Sinning M, Vergara M, Lemus D, et al
    Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study.
    J Neurooncol. 2019 Oct 17. pii: 10.1007/s11060-019-03314.
    PubMed     Abstract available


  393. JANSEN E, Hamisch C, Ruess D, Heiland DH, et al
    Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification.
    J Neurooncol. 2019 Oct 16. pii: 10.1007/s11060-019-03316.
    PubMed     Abstract available


  394. YEO KK, Margol AS, Kennedy RJ, Hung L, et al
    Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
    J Neurooncol. 2019 Oct 16. pii: 10.1007/s11060-019-03307.
    PubMed     Abstract available


  395. DOYLE J, Khalafallah AM, Yang W, Sun Y, et al
    Association between extent of resection on survival in adult brainstem high-grade glioma patients.
    J Neurooncol. 2019 Oct 16. pii: 10.1007/s11060-019-03313.
    PubMed     Abstract available


  396. MIZUGUCHI A, Yamashita S, Yokogami K, Morishita K, et al
    Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells.
    J Neurooncol. 2019 Oct 15. pii: 10.1007/s11060-019-03310.
    PubMed     Abstract available


  397. MUSUNURU HB, Witt JS, Yadav P, Francis DM, et al
    Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases.
    J Neurooncol. 2019 Oct 12. pii: 10.1007/s11060-019-03308.
    PubMed     Abstract available


  398. ZHOU X, Yang Y, Ma P, Wang N, et al
    TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway.
    J Neurooncol. 2019 Oct 11. pii: 10.1007/s11060-019-03301.
    PubMed     Abstract available


  399. RESSEL A, Fichte S, Brodhun M, Rosahl SK, et al
    WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
    J Neurooncol. 2019 Oct 1. pii: 10.1007/s11060-019-03293.
    PubMed     Abstract available


  400. PHILIPPE L, Maria K, Tariq A, Sofia M, et al
    Efficacy of Dabrafenib for three children with brainstem BRAF(V600E) positive ganglioglioma.
    J Neurooncol. 2019;145:135-141.
    PubMed     Abstract available


  401. MCCLELLAND S 3RD, Degnin C, Chen Y, Watson GA, et al
    Impact of the American Tax Payer Relief Act on stereotactic radiosurgery utilization in the United States.
    J Neurooncol. 2019;145:159-165.
    PubMed     Abstract available


  402. TULEASCA C, Daniel RT, Levivier M
    A rare case of pituitary oncocytoma successfully treated with single-fraction stereotactic Gamma Knife surgery.
    J Neurooncol. 2019;145:185-187.
    PubMed    


    September 2019
  403. AHRENDSEN JT, Filbin MG, Chi SN, Manley PE, et al
    Increasing value of autopsies in patients with brain tumors in the molecular era.
    J Neurooncol. 2019 Sep 30. pii: 10.1007/s11060-019-03302.
    PubMed     Abstract available


  404. MALOUFF TD, Peterson JL, Mahajan A, Trifiletti DM, et al
    Carbon ion radiotherapy in the treatment of gliomas: a review.
    J Neurooncol. 2019 Sep 30. pii: 10.1007/s11060-019-03303.
    PubMed     Abstract available


  405. LAREIDA A, Terziev R, Grossenbacher B, Andratschke N, et al
    Underweight and weight loss are predictors of poor outcome in patients with brain metastasis.
    J Neurooncol. 2019 Sep 30. pii: 10.1007/s11060-019-03300.
    PubMed     Abstract available


  406. SJOBERG RL, Wu WY, Dahlin AM, Tsavachidis S, et al
    Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study.
    J Neurooncol. 2019 Sep 25. pii: 10.1007/s11060-019-03294.
    PubMed     Abstract available


  407. RUDA R, Pellerino A, Pace A, Carapella CM, et al
    Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
    J Neurooncol. 2019 Sep 25. pii: 10.1007/s11060-019-03277.
    PubMed     Abstract available


  408. SCHIMMEL WCM, Gehring K, Hanssens PEJ, Sitskoorn MM, et al
    Cognitive functioning and predictors thereof in patients with 1-10 brain metastases selected for stereotactic radiosurgery.
    J Neurooncol. 2019 Sep 24. pii: 10.1007/s11060-019-03292.
    PubMed     Abstract available


  409. HOFFMAN DI, Abdullah KG, McCoskey M, Binder ZA, et al
    Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
    J Neurooncol. 2019 Sep 21. pii: 10.1007/s11060-019-03298.
    PubMed     Abstract available


  410. HABETS EJJ, Hendriks EJ, Taphoorn MJB, Douw L, et al
    Association between tumor location and neurocognitive functioning using tumor localization maps.
    J Neurooncol. 2019;144:573-582.
    PubMed     Abstract available


  411. KINSLOW CJ, Garton ALA, Rae AI, Marcus LP, et al
    Extent of resection and survival for oligodendroglioma: a U.S. population-based study.
    J Neurooncol. 2019;144:591-601.
    PubMed     Abstract available


  412. DELAVAR A, Al Jammal OM, Maguire KR, Wali AR, et al
    The impact of rural residence on adult brain cancer survival in the United States.
    J Neurooncol. 2019;144:535-543.
    PubMed     Abstract available


  413. CORREA DD, Braun E, Kryza-Lacombe M, Ho KW, et al
    Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.
    J Neurooncol. 2019;144:553-562.
    PubMed     Abstract available


  414. DAULEAC C, Messerer R, Obadia-Andre N, Afathi M, et al
    Cysts associated with intramedullary ependymomas of the spinal cord: clinical, MRI and oncological features.
    J Neurooncol. 2019;144:385-391.
    PubMed     Abstract available


  415. GUI C, Chintalapati N, Hales RK, Voong KR, et al
    A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
    J Neurooncol. 2019;144:351-358.
    PubMed     Abstract available


  416. OUSHY S, Graffeo CS, Perry A, Stafford SL, et al
    Single-fraction stereotactic radiosurgery for spindle cell oncocytoma: preliminary experience and systematic review of the literature.
    J Neurooncol. 2019;144:325-332.
    PubMed     Abstract available


    August 2019
  417. GARCIA CR, Slone SA, Dolecek TA, Huang B, et al
    Primary central nervous system tumor treatment and survival in the United States, 2004-2015.
    J Neurooncol. 2019;144:179-191.
    PubMed     Abstract available


  418. WEENINK B, van Brakel M, Wijers R, Sillevis Smitt PAE, et al
    Lack of B and T cell reactivity towards IDH1(R132H) in blood and tumor tissue from LGG patients.
    J Neurooncol. 2019;144:79-87.
    PubMed     Abstract available


  419. TRUITT G, Gittleman H, Leece R, Ostrom QT, et al
    Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.
    J Neurooncol. 2019;144:53-63.
    PubMed     Abstract available


  420. BYUN J, Yoo HJ, Kim JH, Kim YH, et al
    Growth rate and fate of untreated hemangioblastomas: clinical assessment of the experience of a single institution.
    J Neurooncol. 2019;144:147-154.
    PubMed     Abstract available


  421. KAULEN LD, Galluzzo D, Hui P, Barbiero F, et al
    Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma.
    J Neurooncol. 2019;144:107-115.
    PubMed     Abstract available


  422. PADEVIT L, Sarnthein J, Stienen MN, Krayenbuhl N, et al
    Smoking status and perioperative adverse events in patients undergoing cranial tumor surgery.
    J Neurooncol. 2019;144:97-105.
    PubMed     Abstract available


  423. KRAMER K, Khan O, Haque S
    Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy.
    J Neurooncol. 2019;144:227-229.
    PubMed    


  424. SHAIKH SS, Kumthekar PU, Mohindra NA
    A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
    J Neurooncol. 2019;144:235-237.
    PubMed    


    July 2019
  425. WINOGRAD E, Rivers CI, Fenstermaker R, Fabiano A, et al
    The case for radiosurgery for brainstem metastases.
    J Neurooncol. 2019;143:585-595.
    PubMed     Abstract available


  426. KO Y, Gwak HS, Park EY, Joo J, et al
    Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer.
    J Neurooncol. 2019;143:553-562.
    PubMed     Abstract available


  427. YOUSEF A, Rutkowski MJ, Yalcin CE, Eren OC, et al
    Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
    J Neurooncol. 2019;143:547-552.
    PubMed     Abstract available


    June 2019
  428. GITTLEMAN H, Cioffi G, Vecchione-Koval T, Ostrom QT, et al
    Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.
    J Neurooncol. 2019;143:251-260.
    PubMed     Abstract available


  429. LO AC, Laperriere N, Hodgson D, Bouffet E, et al
    Canadian patterns of practice for intracranial germ cell tumors in adolescents and young adults.
    J Neurooncol. 2019;143:289-296.
    PubMed     Abstract available


  430. PATEL V, McNinch NL, Rush S
    Diagnostic delay and morbidity of central nervous system tumors in children and young adults: a pediatric hospital experience.
    J Neurooncol. 2019;143:297-304.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: